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Abstract
The neurocentric theory dismissed for decades the role of glia in information handling 
within the central nervous system (CNS). Nevertheless, almost 3 decades ago, this started 
to change and today astrocytes are considered relevant players for this function. Astrocytes 
“listen” to neuronal communication, regulate it, and respond at the cellular and synctitial 
level. Ionotropic glutamate NMDA receptor (NMDAR) is critical in CNS. It mediates synaptic 
neuronal communication and it is involved in different mechanisms. However, NMDAR is 
also expressed by astrocytes, but its functional role in these cells has not been deeply investi-
gated and has been a matter of debate in the last decades. In this chapter, we briefly outline 
NMDAR intracellular transduction pathways initiated by Ca2+ flux. Then, we review chrono-
logically NMDAR expression and function in astrocytes that have been a source of controver-
sies and apparent contradictions. Finally, some insights are presented regarding NMDAR in 
astrocytes in the context of the tripartite synapse concept and the recently described Ca2+ flux–
independent metabotropic-like NMDAR function in astrocytes. Given the complex molecu-
lar nature of NMDAR, its critical role, and the relevance of astrocytes, the study of astrocytic 
NMDAR promises to provide further understanding of CNS physiology and pathology.
Keywords: NMDAR, astrocyte, glutamate, flux-independent, signal transduction, 
tripartite synapse
1. Introduction
The glutamate (Glu) N-methyl D-aspartate receptor (NMDAR) plays a fundamental role in 
the central nervous system (CNS) mediating synaptic neuronal communication based on its 
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ionotropic function. This Glu receptor is sensitive to different coagonist such as glycine (Gly) 
or D-serine (D-Ser), ions (Mg2+, Zn2+, H+), or other molecules such as polyamines. It is involved 
in different functions that include memory, synaptic plasticity, and long-term potentiation 
and depression (LTP and LTD) among others [1, 2]. This central role in CNS is given mainly 
by its location in the postsynaptic membrane, where it mediates neuronal communication 
enabling extracellular (EC) Ca2+ and Na+ entry into the postsynaptic neuron. Functionally, at 
resting membrane potential, neuronal NMDAR is inactive because its pore is blocked by an 
Mg2+ ion. This scenario is modified when the presynaptic neuron depolarizes and releases 
vesicular Glu into the synaptic cleft. This in turn activates AMPA and Kainate ionotropic 
receptors that depolarize the postsynaptic membrane, thus allowing Mg2+ removal from the 
NMDAR pore and therefore its opening with the consequent cationic flux in response to Glu 
and coagonist binding. For this reason, neuronal NMDAR is considered a coincidence detec-
tor that requires both membrane depolarization and ligand binding [1, 2].
NMDAR is a tetramer of homodimers or a heterotrimer conformed by two obligate subunits 
GluN1 coupled to GluN2 and/or GluN3 subunits. There is only one gene (Grin1) for GluN1 
subunit that is present in all NMDAR described so far, since it plays a central role in NMDAR 
assembly in the endoplasmic reticulum (ER). There, GluN1 regulates NMDAR exit from this 
organelle due to ER retention signals that are masked after its assembly. In addition, there 
are four GluN2(A-D) genes (Grin2a-d) and two genes for GluN3 (A and B; Grin3a-b). It is well 
known that the mRNA of some of these genes undergoes posttranscriptional modification by 
alternative splicing, generating molecular variants that confer specific functional properties 
to NMDAR. This diversity of subunits also allows the assembly of different NMDAR accord-
ing to subunits expressed by the cell, resulting in receptors with different features in terms 
of modulation, traffic, location, and biophysical properties, given in part by their interaction 
with different molecular partners. In addition, there are some posttranslational modifications 
of these subunits that also generate functional variants of NMDAR, such as phosphorylation, 
myristoylation, and proteolytic cleavage, among others [1, 2]. In the CNS, the expression of 
NMDAR subunits is regionalized, and notably, NMDAR is expressed by nonneuronal cells 
but also is widely expressed in cells from different mammal tissues including skin, testis, and 
pancreas, among many others [1–3].
All NMDAR subunits share a common structure with an EC region of ≈500 amino acids (aa); 
three transmembrane domains and two loops, the first one intracellular (IC) and the second 
EC; and an IC C-terminal domain that ranges from ≈200 aa in GluN1 and GluN3 subunits to 
≈500 aa in GluN2 subunits (Figure 1). The EC region is comprised of two functional domains: 
the N-terminal domain (NTD) involved in subunit-subunit molecular interactions and the 
ligand binding domain (LBD) that in close interaction with the EC loop shapes the ligand 
binding site, Glu for GluN2 subunits and Gly or D-Ser for GluN1 and GluN3 subunits. The 
IC C-terminal domain mediates NMDAR molecular interactions that regulate its functional 
properties, for instance in the synapse with the postsynaptic density proteins that mediate the 
assembly of molecular clusters [1, 2].
NMDAR is a cationic channel with partial selectivity for Ca2+ conduction, explained at least in 
part by the DRPEER motif that binds this ion and is present near the second transmembrane 
domain of GluN1 that directly contacts the pore wall [2]. The entry of Ca2+ through NMDAR 
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activates different IC signaling pathways that seem to depend upon its synaptic or extrasyn-
aptic location (Figure 2 and see below). It is well known that these pathways are involved in 
neuronal survival, growth, and differentiation, among other functions. On the other hand, 
it is also known that the excessive and persistent activation of NMDAR may result in the 
mechanism known as excitotoxicity, elicited by the excess of Ca2+ entry and the activation of 
IC pathways that lead to neuronal death (see below) [4, 5]. These Ca2+-dependent IC path-
ways activated by NMDAR have also been referred to as Ca2+ flux–dependent metabotropic 
signaling [6].
Despite its wide expression and distribution in cells and tissues of mammals [3], NMDAR has 
been studied mainly in the neuronal context as a cationic channel [1, 2]. Nevertheless, now 
we know that NMDAR is expressed not only by other cells of the CNS such as astrocytes or 
oligodendroglia but also in non-CNS cells such as endothelium, platelets, and lymphocytes, 
among others [3, 7–9]. Moreover, there are some reports that have demonstrated NMDAR 
Ca2+ flux–independent functions and signaling [10–15], but only few of them have explored 
the molecular mechanisms that underpin this function.
Within the CNS, the role of astrocytes has transformed in almost a century from being con-
sidered supporting and metabolic cells to that of starring players in synaptic transmission 
among other functions. Indeed, since 1999, the concept of the tripartite synapse was coined by 
Araque et al. [16]. According to this idea, astrocytes play a relevant role beyond that of sup-
porting cells, given their neurotransmitter receptor expression, neurotransmitter secretion, 
and IC Ca2+ waves elicited by neurotransmitters together with the early observed position of 
astrocytes that contact synapses and blood vessels. In this context, nowadays, a large amount 
of information supports the role of these cells in different CNS functions including synaptic 
transmission, synapse formation, development, LTP, and complex functions such as memory, 
sleep, and respiration, among many others [17] .
Figure 1. NMDAR subunit and channel structure (see text for details).
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Figure 2. Ca2+ flux–dependent metabotropic signaling pathways in NMDAR. (A) Prosurvival, antiapoptotic pathways. 
(B) Prodeath, proapoptotic pathways (see text for details).
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The aim of the present chapter is to review the expression and function of NMDAR in astro-
cytes, cells in which this topic has been a matter of debate and apparent contradictions. These 
have emerged mainly because astrocytes do not elicit action potentials as neurons do and thus 
NMDAR activation paradigm cannot be achieved, but also because NMDAR in astrocytes 
presents singularities not observed in neuronal NMDAR. Nevertheless, now there is a good 
amount of experimental evidence that has demonstrated NMDAR function in these cells.
In the first section of this chapter, we outline the Ca2+ flux–dependent metabotropic IC trans-
duction pathways started by NMDAR activation, studied in the context of synaptic function, 
to substantiate the diversity of IC signals activated by this receptor. We then account chrono-
logically the findings regarding the expression and function of NMDAR in astroglia that have 
been matter of some controversies and apparent contradictions. Finally, some insights are 
presented regarding NMDAR expression by astrocytes, with special attention to the tripartite 
synapse concept, and the Ca2+ flux–independent metabotropic-like NMDAR function recently 
reported. Given the complex molecular nature of NMDAR, its critical role in the CNS, both 
studied mainly in the neuronal context, and the relevance of astrocytes in the CNS evidenced 
in the last decades, the reexamination of NMDAR functions in astroglia may provide the basis 
to further gain insight into brain physiology and pathology.
2. NMDAR Ca2+ flux–dependent IC signaling
Until today, the canonical function of NMDAR is that of a cationic channel with partial selec-
tivity for Ca2+. This ion has been described in multiple signaling pathways ranging from 
bacteria to mammals and probably possesses the greatest universality and versatility as a sec-
ond messenger [18]. Several IC signaling pathways are activated depending upon Ca2+ entry 
through NMDAR, and some mediate signaling to cell nucleus where gene expression is regu-
lated (Figure 2) [5, 18, 19]. These Ca2+ dependent IC pathways triggered after NMDAR activa-
tion have been also referred as NMDAR metabotropic signaling [6]. The diversity of these IC 
pathways is influenced by NMDAR location and organism age among other variables [1, 20, 
21]. Importantly, Ca2+-dependent IC signaling mediates NMDAR function in LTP, memory, 
learning, neuronal plasticity, and survival, among other mechanisms but also mediates Glu 
excitotoxicity that leads to neuronal death [5].
Notably, there is a signaling dichotomy of NMDAR that has long been acknowledged [22]. A 
good amount of evidences supports divergent signaling between synaptic (prosurvival, anti-
apoptotic) and extrasynaptic (prodeath, proapoptotic) NMDAR [5], and even their genomic 
programs have been analyzed [23]. Interestingly, synaptic NMDAR is mainly assembled by 
GluN1/GluN2A subunits, whereas extrasynaptic NMDAR is mainly assembled by GluN1/
GluN2B subunits [5, 24]. However, this dichotomy has presented inconsistencies in some 
tested models [25]. In the following subsections, we outline the IC signaling evoked by 
NMDAR that for convenience is separated into prosurvival, antiapoptotic signaling and pro-
death, proapoptotic signaling. Since the review of these pathways is not the aim of this work, 
we invite the reader to please refer to the cited reviews and references therein for further 
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 information. Although some of these pathways have also been investigated in astrocytes, it 
must be considered that their involvement must be contextual since NMDAR in astrocytes 
contains different assembled subunits and these cells perform distinct functions.
On the other hand, as mentioned above, some reports have found that NMDAR also activates 
IC pathways independently of Ca2+ flux in neurons and astrocytes, also termed Ca2+ flux–inde-
pendent metabotropic-like signaling, although its molecular mechanisms have been poorly 
studied. This kind of signaling is described in the section of NMDAR in astrocytes since recent 
work has demonstrated its occurrence in these cells, and then it is analyzed in the following 
section.
2.1. Prosurvival, antiapoptotic signaling
2.1.1. Calmodulin (CALM) pathway
One of the central pathways, if not the central one, associated with NMDAR Ca2+ flux is that of 
calmodulin (CALM). This small protein (148 aa) is a Ca2+ sensor that in turn activates the func-
tion of different enzymes, ion channels, aquaporins, and other proteins [26]. Consequently, 
CALM activation is a critical, necessary step for the activation of several downstream path-
ways associated with NMDAR. Malenka et al. demonstrated that CALM and CaMKII activa-
tion is necessary to induce LTP in rodent hippocampal slices. In their experiments, IC injection 
into CA1 pyramidal cells of calmidazolium (CALM antagonist) or a CALM-binding peptide 
blocked LTP [27]. Later, it was found that c-fos NMDAR-dependent activation required 
CALM activity in cultured rat hippocampal neurons, thus suggesting that CALM mediates 
signaling to cell nucleus [28]. In addition, CALM itself was found to modulate NMDAR func-
tion through its interaction with GluN1 subunit [29]. For a review of CALM functions in 
NMDAR signaling, please refer to the work by Xia and Storm [26].
2.1.2. Ca2+/calmodulin-dependent protein kinase (CaMK) pathway
Consistent with the central role of CALM in NMDAR signaling, one of the most studied 
pathways is that of Ca2+/calmodulin-dependent protein kinase (CaMK), of which two iso-
forms are active in NMDAR signaling. The role of these serine/threonine kinases was dem-
onstrated by Bading et al. [28], who found in cultured rat hippocampal neurons that NMDAR 
triggered activation of CaMK (CaMKII, because of the inhibitors tested), since the addition 
of DL-2-Amino-5—phosphopentanoic acid (APV or AP-5), a competitive NMDAR antagonist, 
decreased CaMK activity. Furthermore, also in cultured rat hippocampal neurons, Ca2+/CALM 
induced binding of CaMKII to the cytoplasmic domain of GluN2B, resulting in the translo-
cation of the kinase to the synapse, allowing the persistent CaMKII activity and facilitated 
response to extracellular Ca2+, mechanisms that regulate and potentiate synaptic strength [30]. 
CaMKII is involved in multiple neuronal functions such as LTP [31], dendritic spine density 
[32], and neuronal survival [20, 33], among others. These functions are achieved through activa-
tion of several downstream signaling pathways such as Ras/mitogen-activated protein kinase 
(MAPK) pathway and neuronal nitric oxide synthase (nNOS), among others (see below). For a 
review on the role of CaMKII in the synapse, please refer to the recent reviews [31, 34].
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On the other hand, CaMKIV has also been involved in NMDAR-mediated functions. One of the 
earliest reports on NMDAR-dependent CaMKIV activation was that by Impey et al. [35]. Their 
results in cultured rat primary hippocampal neurons suggested that activation of CaMKIV 
is dependent upon NMDA, since APV treatment blocked its downstream signaling. In addi-
tion, NMDAR-mediated transcription was attenuated by treatment with CaMKIV inhibitors or 
in CaMKIV dominant-negative models [35]. CaMKIV has been extensively studied in down-
stream pathways, such as that of cAMP response element-binding protein (CREB; see below).
2.1.3. Ras/mitogen-activated protein kinase (MAPK) pathway
One of the most important and studied IC pathways activated by CaMKII is the Ras/MAPK 
pathway. Ras GTPase is a key molecule since when it is bound to GTP it activates different 
effectors. Raf-1 kinase is one of the effectors that in turn phosphorylates MEK1/2 (mitogen-
activated protein kinase kinase) that phosphorylates and activates extracellular-regulated 
kinase (ERK1/2 or mitogen-activated protein kinase (MAPK)). ERK1/2 activation results in 
the regulation of different genes in the cell nucleus [36].
Bading and Greenberg [37] demonstrated that Glu treatment of cultured rat hippocampal cells 
resulted in the rapid and transient tyrosine phosphorylation of a 39-kilodalton protein sug-
gested to be microtubule-associated protein kinase-2 (or ERK 2). NMDAR was responsible 
since APV blocked this effect that required Ca2+ influx. Later, Yun et al. [38] demonstrated that 
nitric oxide (NO), synthesized by nNOS, is a key player in NMDAR-mediated Ras activation. 
nNOS is a well-known target of CALM and it is activated after NMDAR mediated Ca2+ flux 
[39]. Moreover, NMDAR stimulation failed to activate Ras in nNOS−/− cultured cortical neurons, 
and ERK activation through NO and Ras is Ca2+ flux–dependent through NMDAR [38]. Later, 
it was found that Ca2+/CALM-dependent Ras guanine nucleotide release factor (RasGRF1) 
directly interacts with GluN2B subunit, and this interaction mediates MAPK pathway activa-
tion [40]. For further details on this pathway, please refer to previous reviews [18, 41].
However, not always NMDAR activity leads to ERK activation. It has been shown that under 
certain circumstances ERK can be inhibited by NMDAR generating apoptotic signals (see 
below).
2.1.4. Phosphoinositide 3-kinase (PI3K) pathway
Phosphoinositide 3-kinase (PI3K) is a target of CALM [42]. Chandler et al. [43] demonstrated 
that PI3K-mediated NMDAR induced activation of ERK in cultured cortical neurons, since 
wortmannin (PI3K inhibitor) decreased phospho-ERK2 levels. This observation, together 
with PI3K catalytic subunit binding to phosphorylated GluN2 previously reported, let the 
authors suggest that NMDAR activation could directly mediate PI3K activation. This was 
later confirmed when it was found that exposure to NMDA significantly enhanced phos-
pho-Akt levels in cultured rat cortical neurons [44]. This increase was blocked by MK-801, 
a pore blocker of NMDAR, or APV, but also by wortmannin and KN-93 (CaMKII inhibi-
tor), indicating that PI3K and CaMKII play a role in NMDA activation of Akt/ERK signaling. 
The Akt pathway modulates actin dynamics and promotes the synthesis of proteins through 
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the kinase  mammalian target of rapamycin (mTOR) that in turn phosphorylates the factor 
4E-binding protein (4E-BP) that controls mRNA translation [45].
2.1.5. cAMP response element-binding protein (CREB) pathway
One of the most studied pathways associated to NMDAR/CaMKIV is that of cAMP response 
element-binding protein (CREB), which plays a critical role in synaptic NMDAR-mediated 
neuroprotection. Impey et al. [35] showed that NMDAR activates transcription of CREB-
responsive genes in cultured rat hippocampal neurons. CaMKIV was responsible for phos-
phorylating CREB-binding protein (CBP), a CREB coactivator. Moreover, mutation of CBP 
Ser301 impaired NMDAR and CaMKIV-stimulated transcription, whereas dominant- negative 
CaMKIV inhibited NMDAR-mediated activation of CREB-CBP. These authors showed that 
CaMKIV mediated a transient early phase of NMDAR-dependent CREB phosphorylation, 
while MAPK mediates a later persistent phase, suggesting the convergence between MAPK 
and CaMKIV pathways. In addition, the transducer of regulated CREB activity 1 (TORC1) 
modulates NMDAR-dependent CREB activation. Although the role of TORC1 in LTP had 
been previously demonstrated [46], Sasaki et al. [47] found NMDAR-dependent TORC1 tran-
scription activation mediated by CaMKIV and salt-inducible kinase 2 (SIK2) degradation after 
oxygen-glucose deprivation (OGD).
Multiple genes related to cell survival are upregulated by NMDAR-dependent CREB activa-
tion. Nonetheless, it has been found that NMDAR activity-dependent shut off of genes is 
also an important process for neuronal survival. Zhang et al. [48] found in cultured mouse 
hippocampal neurons that NMDAR-mediated CREB regulation of Aft3 required nuclear Ca2+ 
transients and CaMKIV activity. Aft3 acts as a transcriptional repressor and protects neu-
rons from apoptosis and extrasynaptic NMDAR-induced cell death triggered by NMDA or 
OGD. For a review, please refer to the work by Hardingham [5].
2.1.6. T-cell lymphoma invasion and metastasis 1 (Tiam1)
Tolias et al. [49] identified Rac-1 guanine nucleotide exchange factor (GEF) Tiam1 as a mol-
ecule involved in NMDAR downstream signaling. Tiam1 interacts and colocalizes with 
NMDAR that after activation allows Tiam1 phosphorylation, depending upon Ca2+ flux. It is 
suggested that such phosphorylation is mediated by CaMKII since it phosphorylates Tiam1 
and increases Rac1 GTP exchange [50]. Using Tiam1 RNAi-infected neurons, this GEF was 
found to be necessary for NMDAR-dependent activation of Akt and phosphorylation of 
4E-BP that mediates NMDAR-dependent mRNA translation [49].
2.1.7. Cofilin/calcineurin pathway
Calcineurin is a Ca2+/CALM-dependent serine/threonine protein phosphatase that in neu-
rons was found to downregulate NMDAR itself after its activation by Ca2+ entry through 
NMDAR [51]. In this work with acutely isolated adult rat neurons, the duration of NMDA 
channel openings is prolonged when calcineurin is inhibited by okadaic acid (phosphatase 
inhibitor) or its specific inhibitor FK506. On the other hand, it was found that NMDAR activa-
tion enhanced F-actin content in dendritic spines, associated to LTP, and such increase was 
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 mediated by cofilin deactivation that stimulates actin filament turnover and therefore growth 
and development of dendritic spines [52].
2.1.8. Serum response factor (SRF) and ETS domain containing protein (Elk-1)
The transcription factors serum response factor (SRF) and ETS domain containing protein 
(Elk-1) were found to mediate NMDAR Ca2+-dependent transcriptional response in cultured 
rat hippocampal neurons [53]. In this work, it was determined that c-fos gene transcription 
through the serum response element (SRE) present in its promoter could be achieved by two 
different pathways: one by SRF independent of Elk-1 and the second dependent upon Elk-1 
phosphorylation, mediated by ERK.
2.1.9. p53 and p53 upregulated mediator of apoptosis (PUMA) suppression
NMDAR has also been shown to inhibit proapoptotic factors. Lau and Bading [54] demon-
strated in cultured mouse hippocampal neurons that synaptic NMDAR suppressed p53 expres-
sion. This effect was blocked by MK-801 and included the repression of proapoptotic p53 target 
genes apoptosis protease activating factor 1 (apaf1) and p53 upregulated modulator of apopto-
sis (PUMA). Léveillé et al. [55] demonstrated that in cultured mouse cortical neurons, blockage 
of NMDAR with MK-801 induced the activation of caspase-3/7 following an apoptotic insult. 
They also confirmed that synaptic NMDAR protected neurons by suppressing the expression 
of proapoptotic PUMA that through Bcl2 associated X protein (Bax) promotes mitochondrial 
release of apoptotic factors, such as cytochrome C, and facilitates the action of proapoptotic 
members of the Bax subfamily. Released cytochrome C binds to APAF-1, which oligomerizes 
and recruits procaspase-9 that then becomes activated, forming the apoptosome [56].
2.2. Prodeath, proapoptotic signaling
2.2.1. ERK pathway inhibition
Chandler et al. [43] found an ambivalent ERK regulation by NMDAR in rat neuronal cultures. 
High concentration of NMDA decreased phospho-ERK2 levels in 1 mM extracellular Ca2+, 
but activated it in 100 μM extracellular Ca2+. The inhibition was accompanied by a decrease of 
phospho-CREB. Later, Ivanov et al. [57] demonstrated in cultured rat hippocampal neurons 
that ERK activation or inhibition depended upon the pool of NMDAR activated. Synaptic 
NMDAR activated ERK, whereas extrasynaptic NMDAR inhibited it. However, more recently, 
it was reported that ERK pathway activation in cultured rat cortical neurons depended on the 
days in vitro (DIV) of the culture and NMDA concentration. However, effects were sensitive to 
ifenprodil (GluN2B receptor antagonists), thus suggesting that GluN2B containing NMDAR 
may activate or inhibit ERK pathway [21].
2.2.2. Synaptic Ras GTPase-activating protein (SynGAP)
Synaptic Ras GTPase-activating protein 1 (SynGAP1) has been shown to interact with PDZ 
domain containing proteins such as postsynaptic density protein 95 (PSD-95), in the PSD, 
where it exists as a macromolecular complex together with the NMDAR subunit GluN2B [58]. 
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SynGAP is inhibited by its phosphorylation by CaMKII that in turn stops inactivation of Ras 
that leads to MAPK pathway activation [59]. In cultured rat hippocampal neurons, they used 
RNAi to specifically suppress SynGAP expression that resulted in sustained ERK activation 
following NMDAR stimulation instead of transient activity [58].
2.2.3. Forkhead box protein O (FOX O)
Forkhead box protein O (FOXO) class of transcription factors can promote neuronal death 
[60]. FOXO targets proapoptotic genes including Bcl2-interacting mediator of cell death (Bim), 
PUMA, and Fas ligand (FasL), among others. It has been demonstrated in cultured rat cortical 
neurons that synaptic NMDAR prevents FOXO nuclear export and suppression of FOXO1 
gene through PI3K/Akt activation [61]. Similarly, Dick and Bading [62] found that in cultured 
rat hippocampal neurons, synaptic activity inhibits nuclear translocation of FOXO3 and that 
dominant negative CaMKIV(K75E) expression blocked protective activity. Contrarily, extra-
synaptic NMDAR activity induced FOXO3 nuclear import resulting in apoptosis.
2.2.4. Juxtasynaptic attractor of caldendrin on dendritic boutons (Jacob)
A binding partner of the neuronal Ca2+-binding protein caldendrin critical for extrasynaptic 
NMDAR signaling was identified named juxtasynaptic attractor of caldendrin on dendritic 
boutons protein (Jacob) [63]. These authors found that Jacob knockdown prevented CREB shut 
off after extrasynaptic NMDAR activation. When imported into the nucleus, Jacob causes CREB 
dephosphorylation and promotes apoptosis, effects prevented by Caldendrin, which binds 
Jacob in a Ca2+-dependent manner elicited by synaptic NMDAR activity. Contrarily, extrasyn-
aptic NMDAR activity promoted nuclear accumulation of Jacob and neuronal death [5, 63].
2.2.5. Calpain/p38 MAP pathway
The calpain pathway is another important pathway that is related to the extrasynaptic activ-
ity of NMDARs. Calpain is a Ca2+-dependent protease that has been widely implicated in 
neurotoxicity [64]. Xu et al. [65] demonstrated that in cultured rat cortical neurons the activa-
tion of extrasynaptic NMDARs strongly activates calpains, whereas synaptic NMDAR fails 
to activate this protease. Striatal-enriched protein tyrosine phosphatase 61 (STEP61) is a sub-
strate for calpain and is rapidly cleaved after strong glutamatergic stimulation such as during 
excitotoxic or ischemic insult [66, 67]. Extrasynaptic stimulation of NMDARs evoked calpain-
mediated proteolysis of STEP61 and activation of p38 MAPK. p38 contributes to cell death 
induced by chronic NMDA or Glu exposure [65]. Previously, Kawasaki et al. [68] observed 
p38 activation after Glu treatment in mature cerebellar granule cells, mediated by NMDAR.
3. Chronological track of NMDAR expression and function 
in astroglia
When considering the role of NMDAR in astrocytes, it is convenient to first acknowledge 
the hypothesis made by nineteenth century scientists such as Fridtjof Nansen, William Lloyd 
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Adriezen, or Carl Ludwig Schleich who suggested that neuroglial cells could play a more rele-
vant role than that of gluing the CNS, after the name neuroglia was coined by Virchow in 1856 
[17]. After almost a century of studying CNS from the perspective of the neurocentric theory, 
this conception was found to be correct. Previous recent reviews have examined the expres-
sion of NMDAR in neuroglial cells [69, 70]. Here, we present a chronological comprehensive 
review about how the expression and function of NMDAR in astrocytes have been studied in 
the last 40 years. Throughout these decades, different controversies and apparent contradic-
tions have been encountered, but today, NMDAR expression and function in astrocytes are 
well documented and accepted. Moreover, NMDAR in astrocytes could play a relevant role in 
CNS pathologies and therefore offer a window to develop new therapeutic strategies.
In this review, we focus in NMDAR expression and function of brain astrocytes, although we 
recapitulate some early approaches in other neuroglial cells. It must be noted however that dif-
ferent laboratories documented the expression and function of NMDAR in Muller, Bergman, 
and radial glial cells or spinal astrocytes mainly in the 1990s. Please refer to the reviews by 
Dzamba et al. [70] or Verkhratsky and Kirchhoff [69] who examined the work on these cells.
3.1. Is it there? The early years: 1960s, 1970s, and 1980s
In 1967, it was observed that cortical glial cells in situ did not respond to Glu [71]. Later, Hösli 
et al. [72] found that in spinal organotypic cultures, astrocytes depolarized after treatment with 
Glu (100 μM). However, it was postulated that such depolarization was due to K+ released 
by neurons, since 4-aminopyridine (blocker of Kv1 receptors) inhibited such effect and it was 
observed only in astrocytes adjacent to neurons but not in isolated astrocytes. Remarkably, 
no change in membrane resistance was observed in these cells, but neither in astrocytes from 
the olfactory cortex that also responded to Glu [72, 73]. However, few years later, it was dem-
onstrated that neuron-free cultured astrocytes from newborn rat hemispheres responded to 
Glu treatment (100 μM-1 mM) in a Na+-dependent manner. These groups also demonstrated 
that NMDAR was not involved in Glu response of astrocytes, since NMDA treatment alone 
(100 μM-1 mM) did not generate membrane depolarization [74, 75]. Instead, Glu was found to 
open Na+/K+ channels in cultured rat astrocytes that shared many properties with neuronal kain-
ate/quisqualate receptor [76]. This finding was confirmed by Pearce et al. [77] that measured Ca2+ 
efflux and breakdown of inositol phospholipids in cultured rat cortical astrocytes and found 
no response with 100 μM NMDA. Usowicz et al. [78] showed that type-2 cerebellar astrocytes 
also depolarized in response to Glu, and consistently with previous findings, these cells did not 
respond to NMDA application (30–100 μM). Consistently, Backus et al. [79] observed that cul-
tured rat cerebral astrocytes had no change in membrane potential with NMDA, even with the 
coagonist Gly or in Mg2+-free solution, conditions that would favor neuronal NMDAR response. 
These studies, most of them electrophysiological, the traditional approach to study neuronal 
NMDAR, set the basis to establish that astrocytes do not express NMDA-type Glu receptors.
3.2. Rethinking the idea: the 1990s
In the seminal study by Cornell-Bell et al. [80], who described for the first time Ca2+ waves in 
cultured rat astrocytes in response to Glu, establishing the possibility that this kind of signal-
ing could be relevant for CNS function, small inconsistencies regarding the expression of 
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NMDAR in astrocytes were observed. Using the IC Ca2+ (iCa2+) probe Fluo-3, they found that 
cultured astrocytes did not respond to NMDA (100 μM) and Gly, although a small decrease 
of iCa2+ is observable in their published recordings. Nevertheless, these authors noted that 
APV “attenuated” the Glu response, because peak frequency and the amount of iCa2+ between 
peak responses were reduced, although maximal amplitude was maintained. Indeed, APV 
depleted a Glu-dependent gradual increase of iCa2+ masked between peak responses. Despite 
these findings suggesting that NMDAR could somehow be functional in these cells, it was 
concluded that astrocytes did not express NMDAR, consistently with previous reports. 
Simultaneously, Jensen and Chiu [81] also reported a lack of iCa2+ response measured with 
fura-2 in cultured rat cortical astrocytes to NMDA with or without Mg2+. The same year, the 
Cornell-Bell group reported in a different work that Glu induced the formation of filopodia in 
astrocytes of mixed hippocampal cultures; however, this effect was not achieved with NMDA 
alone (100 μM) [82].
After Ca2+ waves’ discovery in cultured astrocytes, Dani et al. [83] demonstrated the existence 
of Ca2+ waves in fluo-3 labeled astrocytes from organotypically cultured slices of rat hippo-
campus. These waves were elicited by neuronal electrical stimulation or bath application of 
NMDA (20 μM). However, since these waves were secondary to Ca2+ rise in neurons, these 
authors inferred that they were indirectly elicited, resulting from neurotransmitter released 
from NMDA-stimulated neurons and not from a direct stimulation of NMDAR in astrocytes.
Later, Holzwarth et al. [84] also found no iCa2+ response measured with Fura-2 to NMDA 
in cultured rat cortical astrocytes, whereas Seifert and Steinhauser [85] did the same obser-
vation in acute isolated mice hippocampal astroglial cells by patch clamp. These results 
reinforced the notion that astrocytes lacked functional NMDAR. However, in parallel and 
contradiction with this conception, two different groups suggested astrocyte activity evoked 
by NMDAR. Steinhauser et al. [86] reported that in postnatal (9–12 days) mice hippocampal 
brain slices, in a small group of glial cells termed passive (34% of them glial fibrillary acidic 
protein + [GFAP+] and characterized by time-independent currents) NMDA (1 or 5 mM) elic-
ited currents detected by patch clamp. However, these responses varied: 41% presented an 
inward current, 32% a small outward current, and 27% did not respond. Nevertheless, these 
authors did not unequivocally identify astrocytic NMDAR as the responsible receptor. The 
second work by Porter and McCarthy [87] was made in rat hippocampal slices from young 
animals (9–13 days) labeled with Fura Red AM or Calcium Green-1 and recorded with confocal 
microscopy. In this work, it was reported that 75% of recorded astrocytes, identified by GFAP, 
presented iCa2+ rise in response to NMDA (50 μM), blocked by APV, although only 45% of 
these responses persisted in the presence of tetrodotoxin (TTX) that blocks neuronal activity. 
These observations suggested that astrocytes have functional NMDAR, although authors con-
sidered that Glu release mediated by presynaptic NMDAR, even with TTX, offered an alterna-
tive explanation for their observations. On the other hand, the other 55% of cells confirmed 
that neuronal activity could also elicit astrocyte responses, as inferred by Dani et al. [83].
In the meanwhile, different groups looked for the expression of NMDAR with histological 
techniques. Conti et al. [88] initially suggested that in the cerebral cortex of adult rats, virtu-
ally all (95.7%) GFAP+ cells did not express the mRNA for GluN1 (NMDAR1 or NR1) as 
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evidenced by in situ hybridization and electron microscopy (EM). Nevertheless, Gracy and 
Pickel [89] found by immunohistochemistry (IHC) combined with EM that in the basolateral 
amygdala 20% of staining with anti-GluN1 antibodies (Abs) corresponded to distal tips of 
astrocytic processes. Moreover, in a second work from Conti [90], it was found by IHC-EM, 
that in the cortex of adult rats, some distal processes and rare cell bodies of astrocytes were 
positive for GluN1 and GluN2A/B, although this was not evident by light microscopy. 
Similarly, Petralia et al. [91] found by IHC-EM and light microscopy in the dorsal cochlear 
nucleus some glial processes and wrappings of the synapses, and therefore possibly astro-
cytes, labeled with Abs against GluN1 and GluN2A/B. Likewise, Bockstaele and Colago [92] 
found in the nucleus coeruleus by IHC-EM the presence of GluN1 in astrocytic processes. 
Also, Farb et al. [93] reported that in the basal nuclei of the amygdala, glial processes were 
labeled by GluN1 Abs, detected by IHC-EM. Therefore, despite initial observations that sup-
ported the notion of astrocytes lacking NMDAR, several studies found evidences supporting 
its expression in tissue astrocytes of different brain regions.
Later, Pasti et al. [94] obtained further evidence with brain slices indicating that iCa2+ increase 
in cortical or hippocampal astrocytes in response to NMDA (100 μM) or neuronal electrical 
stimulation was a secondary effect of neuronal activity, not a direct action on putative astro-
cytic NMDAR. Consistently, Cai and Kimelberg [95] found no response to NMDA (100 μM) 
in GFAP+ acute isolated astrocytes from rat hippocampus. Notably, Gottlieb and Matute [96] 
in the same year found by IHC the expression of GluN2A and GluN2B subunits in rat hip-
pocampus reactive astrocytes after transient ischemia. The expression of these subunits was 
maximal after 28 days of ischemia. This study constituted the first evidence suggesting that 
astrocytic NMDAR could play a role in the development of reactive astrocytes and therefore 
in pathology.
Two years after, Nishizaki et al. [97] detected currents by patch clamp elicited by NMDA (1 mM) 
in human cultured astrocytes obtained from the white matter surrounding a tumor. These 
currents were potentiated by Gly, sensitive to Mg2+, independent of Glu transporters, but curi-
ously were not sensitive to APV. Instead, they were partially sensitive to a G-protein inhibitor 
and increased when iCa2+ was depleted by inhibiting the sarcoendoplasmic reticulum Ca2+/
ATPase (SERCA), suggesting that currents were the result of store-operated Ca2+ entry (SOCE). 
In addition, it was observed with fura-2/AM that iCa2+ increased in response to NMDA, but 
this response was only partially inhibited by extracellular Ca2+ depletion and was also APV 
insensitive. With these findings, the authors suggested that NMDA elicited a response through 
a receptor distinct from NMDAR, perhaps through the activation of G-protein–coupled recep-
tors (GPCR) that released Ca2+ from IC stores. However, Shelton and McCarthy [98] found no 
“clear” iCa2+ response to NMDA (100–400 μM) in rat astrocytes labeled with Calcium Green-1 
AM from hippocampal slices obtained from 30 to 38 day animals, in Mg2+-free solution with 
Gly and TTX. This contrasted with their previous observation in younger animals (9–13 days) 
[87] and led the authors to suggest that NMDAR expression could change during develop-
ment. Simultaneously, Conti, et al. [99] reported that in human cortex, distal astrocyte projec-
tions had GluN1, GluN2A, and GluN2B labeling detected by IHC-EM, whereas astrocyte cell 
bodies were only occasionally labeled. Some of the labeled distal projections of astrocytes sur-
rounded the axon terminal but others were present in areas not related with synapses.
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3.3. It is there and it works: the 2000s
In 2001, Schipke et al. [100] identified functional NMDAR in cortical astrocytes of wild-
type mice and transgenic mice with enhanced green fluorescent protein (EGFP) under con-
trol of GFAP promoter (EGFP-GFAP mouse). These authors isolated EGFP+ cells to obtain 
mRNA, perform RT-PCR, and test NMDAR subunit expression. In these experiments, GluN1, 
GluN2B, and GluN2C were expressed in astrocytes, whereas GluN2A, GluN2D, and GluN3 
were not found. In addition, efforts were made to identify NMDAR subunits by western blot, 
but they were unsuccessful due to low cell yields. Patch clamp experiments in brain slices 
from 7 to 28 day animals showed that NMDA (100 μM) elicited currents in most (72%) of 
EGFP+ cells, but also in astrocytes from wild-type animals. Although the main component of 
these currents was found to be indirectly mediated by neuronal activity as previously identi-
fied, there was also a component related solely to direct NMDAR function in astrocytes. This 
response was blocked by MK-801 and Mg2+ suggesting that NMDAR was similar to neuro-
nal NMDAR. Consistently, using Ca2+ indicators, it was found that NMDA increased iCa2+ 
observed mainly in distal projections, but also in the cell soma, consistently with previous 
ultrastructural observations that identified NMDAR mainly in distal projections.
This same year, Kondoh et al. [101] studied again NMDA (1 mM) responses by patch clamp in 
human astrocytes from the white matter surrounding a tumor. Essentially, the results reported 
were the same and consistent with their previous findings [97], but they also discarded that 
the cultured cells were from tumoral origin. Oddly, NMDA-elicited currents were potenti-
ated by kynurenic acid (KYNA), a nonselective ionotropic Glu receptor antagonist. Also, the 
receptor mediating the response to NMDA was found to be less permeable to Ca2+. With these 
observations, the authors suggested that astrocytes express a novel form of NMDAR, regu-
lated by GPCR, as suggested by their sensitivity to a G-protein inhibitor, perhaps through the 
assembly of particular nondescribed subunits expressed in these cells.
Then, the group by Krebs et al. [102] reported that in rat hippocampus, NMDAR subunits 
GluN1 and GluN2B were observed in GFAP+ cells by IHC 3 days after transient ischemia, 
peaking at 28 days, and declining by 56 days, but were not detected in cells from intact ani-
mals. These observations were consistent with those made by Gottlieb and Matute [96]. In 
addition, GluN1 and GluN2B subunit expression was confirmed in astrocytes from postnatal 
(2–4 days) hippocampal neuron-glia cocultures subject to anoxia, where no neurons survived 
by day 3. In contrast, GluN2B was not found in pure cultured hippocampal astrocytes after 
anoxia. Functionally, NMDA (0.5–1 mM) elicited iCa2+ responses in astrocytes obtained from 
neuron-glia cocultures subject to anoxia or astrocytes acutely isolated from ischemic hippo-
campi. These responses were APV sensitive, and in acute isolated astrocytes, they were par-
tially blocked by ifenprodil. These authors suggested that NMDAR function in astrocytes 
could provide the basis for new therapies to ameliorate the effects of stroke.
The same year, Zhang et al. [103] published a study reporting NMDAR participation in iCa2+ 
responses to Glu in cultured rat cortical astrocytes (87% of cells as described in their follow-
ing publication) using APV. This is to our knowledge the first report that found response to 
NMDA in nonhypoxic cultured rat cortical astrocytes. A year after, the same group published 
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these results but also found that NMDA (50–100 μM) elicited iCa2+ response that was sensitive 
to APV in a large proportion (72%) of cultured rat cortical astrocytes [104]. Interestingly, APV 
inhibition was reverted only after a 30-min incubation in APV-free solution.
Two years later, strong evidence was provided by the group of Verkhratsky indicating that 
NMDAR mediated currents in acute isolated and tissue mouse cortical astrocytes (17–22 days) 
[105]. Profiting the advantages of the EGFP-GFAP mouse model for the identification of astro-
cytes, these authors found three different components of currents elicited by Glu application in 
acute isolated astrocytes using AMPA/kainate receptor, NMDAR, and Glu transporter inhibi-
tors (NBQX, APV, and L-TBOA, respectively). In particular, APV blocked the sustained compo-
nent of the Glu-induced current. They also demonstrated that NMDA elicited robust currents 
potentiated by Gly in 87% of acute isolated astrocytes at −40 or −80 mV membrane potential, 
indicating their insensitivity to Mg2+, in contrast with NMDAR-mediated currents in neurons 
and previous work with hippocampal astrocytes [100]. Robust currents required 10–100 μM 
NMDA but were observable with 30 nM NMDA, they were blocked by MK-801, and ifenprodil 
only partially reduced currents in 43% of cells. Importantly, electrical stimulation of neurons 
in brain slices from 17 to 22 day animals also evoked Mg2+-insensitive cortical astrocyte cur-
rents of which the fast component was blocked by MK-801, suggesting NMDAR involvement. 
Glu transporters also mediated these currents, but in contrast with observations in isolated 
astrocytes, AMPA/kainate receptors were poorly involved, although preventing their desensi-
tization increased current amplitude. Interestingly, miniature spontaneous currents were also 
observed in tissue astrocytes that were independent of TTX, partially blocked by APV (32%) 
but fully blocked by APV and NBQX combination. All in all, this work demonstrated that 
astrocytes express functional NMDAR that mediate neuron-astrocyte communication.
Contrary to these findings, the same year different groups reported that NMDAR is not 
involved in iCa2+ response of astrocytes. Wang et al. [106] investigated astrocyte Ca2+ activity in 
the barrel cortex of adult mouse (6–8 weeks) in response to whisker stimulation. In this work, 
it was found that iCa2+ activity in astrocytes was consistently triggered by whisker stimulation. 
However, iontophoretic application of APV did not modify astrocytic iCa2+ activity although 
postsynaptic currents were suppressed, suggesting that astrocytic NMDAR is not involved 
in their response. In addition, Serrano et al. [107] studied glial involvement in heterosynaptic 
depression in rat (14–21 days) hippocampal slices. Although these authors found that NMDA 
elicited iCa2+ responses in astrocytes that were blocked by APV, these responses were delayed 
minutes after NMDA application. Indeed, TTX revealed that these glial responses were indi-
rect and mediated by neuronal activity, as previous works had reported. Likewise, Kato, et al. 
[108] found in cultured cortical astrocytes from newborn mouse that NMDAR antagonists 
MK-801, ifenprodil, or Ro25-6981 did not block iCa2+ rise in response to Glu, as it was observed 
in cultured neurons. Notably, Glu induced astrocytes’ activation (measured by morphological 
changes and GFAP expression) in neuron/astrocyte cocultures or cultured astrocytes, but this 
effect was blocked by MK-801 or ifenprodil only in neuron/astrocyte cocultures. This supported 
that neuronal NMDAR mediated neuron-glia signaling mediated astrocyte activation, resem-
bling previous observations made in tissue astrocytes. In addition, Edling et al. [109] found 
that c-fos induction by Glu in newborn rat cultured astrocytes was not blocked by MK-801.
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In 2008, a transcriptome database for three cell types of the CNS (neuron, astrocyte, and 
oligodendrocyte) from mouse forebrain was published, describing developmental changes 
between postnatal days 1 and 30 [110]. In this work, astrocytes were isolated by fluorescence-
activated cell sorter (FACS) from a transgenic mouse expressing EGFP under control of 
S100β promoter, an astrocyte marker. Results showed that in vivo but also cultured astro-
cytes express NMDAR subunits GluN1, GluN2C, and GluN3A, the subunits included in the 
arrays. In particular, GluN2C was enriched in mature astrocytes. Importantly, after expres-
sion profile analysis, the authors observed that cultured astrocytes expressed many of the 
genes expressed by in vivo astrocytes and did not express the enriched genes in neurons or 
oligodendrocytes. However, they concluded that cultured astrocytes do not represent the 
same cell type as in vivo astrocytes, but instead an immature stage of the astrocyte lineage or 
a reactive astrocyte phenotype.
Simultaneously, Serrano et al. [111] found evidence suggesting astrocytic NMDAR function in 
the hippocampus, in contrast to their previous findings. These authors first distinguished two 
populations of cells in hippocampal slices from the EGFAP-GFAP mouse (10–18 day). These 
cells had different current/voltage curves, GFP levels, and cell-coupling and therefore were 
designated linear and outward rectifying glial cells (probably NG2+ cells). NMDA (25 μM) 
depolarized both types of cells, but in linear glial cells, TTX blocked partially (43%) the depo-
larization, while in outward rectifying cells, TTX had no effect. These observations suggested 
the direct involvement of astrocytic NMDAR beyond an indirect role mediated by neuronal 
activity as suggested by their own work and other previous reports. These authors further 
suggested that diversity of glial cells in the hippocampus could underpin distinct observa-
tions regarding NMDAR function in hippocampal astrocytes.
3.4. NMDAR composition, peculiar function, and therapy window: the 2010s
Palygin et al. [112] reported again that acute isolated astrocytes from EGFP-GFAP mouse 
(3 months) elicited currents in response to NMDA (30 μM). These currents presented slow 
desensitization kinetics, were blocked by APV, and were insensitive to Mg2+ as previously 
reported by the same group [105]. In addition, NMDA (30 μM) also elicited iCa2+ responses in 
acute isolated astrocytes measured with Fura-2 that were 43% of that elicited with Glu. iCa2+ 
responses were also evoked in astrocytes from cortical slices by neuronal electrical stimulation 
and were proportional to stimulus intensity. The iCa2+ response was blocked by TTX (100%) 
or decreased by APV (34%) or UBP141 (29%; antagonist of GluN2C/D containing NMDAR). 
With these results, the authors confirmed that astrocytic NMDAR participated in neuron-glia 
signaling and suggested that they should be assembled with GluN2C/D subunits and GluN3 
that could provide lack of Mg2+ block and low Ca2+ permeability.
The same year, Lee et al. [113] reported that human astrocytes also expressed functional 
NMDAR. In this work, all seven NMDAR subunits were detected by RT-PCR in cultured 
astrocytes from fetal brains or adult brains and by immunofluorescence in human cultured 
fetal astrocytes. They found iCa2+ responses measured with Fura-2 to Glu (20 μM- 2.5 mM) or 
quinolinic acid (QUIN; agonist of NMDAR; 40 nM- 5 μM) that were blocked by MK-801 or 
memantine (NMDAR antagonist). However, three aspects were atypical in these  experiments: 
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(a) responses to Glu and QUIN were not transient but sustained even after 30 s of agonist 
removal; (b) disparate concentrations of Glu (500 μM) and QUIN (1 μM) were required to 
elicit a similar iCa2+ response; and (c) these experiments were made with a fluorometer despite 
employing live microscopy. On the other hand, cytotoxicity levels induced by Glu or QUIN 
were prevented by MK-801 or memantine, but again Glu and QUIN concentrations to achieve 
the same response were disparate (500 μM vs. 500 nM, respectively).
After, Jiang et al. [114] reported that in cultured rat cortical astrocytes the NO donor sodium 
nitroprusside (SNP) or NMDA (10 μM for 18 hrs) induced Carboxyl-terminal PDZ ligand of 
nNOS (CAPON) translocation form cytoplasm to cell nucleus. The authors assumed NMDAR 
function since SNP effect was prevented by MK-801. Extraordinarily, they observed that SNP 
induced GluN2B localization in the cell nucleus, supporting previous findings suggesting 
putative NMDAR nuclear translocation [115, 116]. On the other hand, Zhou et al. [117] char-
acterized NMDAR subunit expression in mouse cultured astrocytes at different times and in 
a model of ischemia. They found GluN1, GluN2A, and GluN2B expression by RT-PCR and 
immunofluorescence (only GluN1 and GluN2B). The expression of GluN1 decreased with 
time (4 weeks), GluN2A was increased, and GluN2B was slightly increased. Ischemia, actu-
ally an incubation in medium without serum, glucose, and equilibrated with 85% N2 and 0% 
O2, caused a bell-shaped response in GluN1, GluN2A, and GluN2B gene expression.
The following year, a study by Palygin et al. [118] characterized pharmacologically the 
NMDAR in acute isolated cortical astrocytes from the EGFP-GFAP mouse (4–8 weeks). In 
these cells, NMDA (50 μM) evoked inward currents in all astrocytes tested that were inhib-
ited by UBP141 (62%) and were Mg2+ independent, whereas in neurons, only a slight inhibi-
tion was observed (9%) and they were Mg2+ dependent. Ifenprodil did not block astrocyte 
responses (3%), whereas it had a marked effect on neurons (58%). Memantine at low concen-
tration blocked mainly astrocyte responses (39%) but not neuronal responses (7%), whereas 
at high concentration, it blocked both responses by 72% in astrocytes and 46% in neurons. In 
addition, using cortical brain slices, astrocyte and neuronal synaptic responses to NMDA or 
afferent stimulation were recorded. Astrocyte currents were dependent (TTX blocked them) 
and proportional to neuronal activity, therefore termed glial synaptic currents (GSC), but had 
slower rise and decay times compared with neuronal responses. In these experiments, simi-
lar results were observed to those observed in acute isolated cells with UBP141, ifenprodil, 
and memantine. When MK-801 was applied to astrocytes intracellularly, their response was 
decreased and no further effect was achieved with UBP141 or APV, although Glu transporter 
inhibitors almost fully abolished astrocytic response. In addition, measuring simultaneously 
iCa2+ with Fluo-3 and currents in astrocytes, it was found that NMDAR contributes impor-
tantly (89%) to current response, whereas it mediated approximately half of iCa2+ response 




) of astrocytic NMDAR was calculated and found 
lower than that of neurons (3.4 astrocytes vs. 7.5 neurons), as suggested previously. This 
value is similar to that of NMDAR containing GluN3 subunits and together with Mg2+ inde-
pendence suggested that GluN3 subunits are assembled into NMDAR of astrocytes. These 
authors also obtained evidences suggesting that diheteromeric (GluN1/GluN3) NMDAR is 
present in astrocytes. Together, these findings indicated that NMDAR in cortical astrocytes is 
assembled with GluN1, GluN2C or D, and GluN3 subunits.
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Later the same year, the same group reported the participation of NMDAR, AMPA, and P2X 
receptors and Glu transporters in astrocyte responses to synaptic activity using the same 
model [119]. Their results showed that the participation of these molecules change in time. In 
particular, NMDAR increases its participation in both evoked and spontaneous GSC from the 
young (1 month) to adult (6 months) animals, declining in old animals (18–21 months). The 
same behavior was observed for membrane current density and iCa2+.
Also in 2011, Martins de Souza et al. [120] published a proteome analysis of cultured astro-
cytes (cell line 1321 N1) treated with MK-801 or clozapine, performed with 2D gel electropho-
resis followed by MALDI-TOF/TOF mass spectrometry. MK-801 treatment (8–72 h) regulated 
the expression of different proteins that belong to the energy pathway, cell communication, 
or cell growth, among others.
One year later, Gerard and Hansson [121] published a paper in which they described that rat 
cortical astrocytes cocultured (9–11 days) with endothelial cells presented iCa2+ responses to 
NMDA (100 nM-100 μM) measured with Fura-2. These responses were fully blocked by APV 
or ifenprodil, indicating that NMDAR with GluN2B subunit mediated these responses, sub-
unit that was detected by immunofluorescence. Interestingly, the amplitude of these responses 
was blocked only partially (50%) in Ca2+-free solution or with Cd2+. Moreover, Ca2+ depletion 
from IC stores with caffeine and thapsigargin almost fully blocked (90%) response amplitude, 
whereas a combination of IC Ca2+ depletion and extracellular Ca2+-free solution fully blocked the 
response. These results indicated that the source of Ca2+ was mainly the IC pools. Consistently, 
xestospongin C (XesC; inhibitor of inositol tris-phosphate [IP3] receptors) importantly (80%) 
diminished iCa2+ response amplitude and in combination with Ca2+-free extracellular solution 
reached more than 90% inhibition. These authors also found that lipopolysaccharide (LPS) 
treatment increased NMDA iCa2+ response or IL-1β secretion, effects blocked by APV or ifen-
prodil. These results constituted the first suggestion that in cultured astrocytes the NMDAR 
could elicit a metabotropic-like flux-independent response beyond its ionotropic function, 
although these authors did not rule out the possibility that this response was actually a Ca2+-
induced Ca2+ release (CICR). Few groups had previously reported that some neuronal func-
tions were mediated by a metabotropic-like, Ca2+ flux–independent NMDAR [12].
In 2013, a new expression profile analysis for young (2.5 months) and old (15–18 months) 
mouse astrocytes and microglia was published [122]. In this work, astrocytes were isolated 
from mouse brain through FACS using Glu transporter-1 (GLT-1) labeling. The mRNA of 
these cells was obtained, and cDNA was synthesized and then hybridized in an expression 
array. Consistent with the work by Cahoy et al. [110], astrocytes were enriched with GluN2C 
subunit expression in young and old astrocytes. Similar to the previous transcriptome analy-
sis, these authors also found glutamate ionotropic receptor NMDA-type subunit-associated 
protein 1 (Grina) high expression. In addition, young astrocytes expressed higher levels of 
GluN3A in comparison to old astrocytes. Unfortunately, when this review was written, the list 
of genes in the arrays used were not publicly available and therefore it could not be confirmed 
which other subunits of the NMDAR were included in this array. Certainly, the expression 
of GluN2 and GluN3 subunits without GluN1 would not result in NMDAR assembly in the 
ER and transport to the plasma membrane, given the current paradigm and therefore GluN1 
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subunit expression is inferred. Rusnakova et al. [123] also published a study in which expres-
sion of NMDAR subunits was confirmed by single cell quantitative RT-PCR in acute isolated 
astrocytes from postnatal EGFP-GFAP mouse brains at days 10, 20, 30, and 50. In this work, 
NMDAR subunits GluN1, GluN2A, GluN2B, GluN2C, GluN2D, and GluN3A were expressed 
with different levels by these cells. In addition, this study also confirmed the expression of 
these NMDAR subunits at 3, 7, and 14 days after ischemia.
A new transcriptome database was published later by the Barres group based on RNA library 
sequencing [124]. This database included several brain cell types: neurons, astrocytes, myelina-
ting, new and precursor oligodendrocytes, microglia, endothelium, and pericytes. In particu-
lar, cortical astrocytes were isolated from a transgenic mouse expressing EGFP under control of 
aldehyde dehydrogenase (Aldh 1 l1) promoter. In the open database at the Stanford University 
site, astrocytes are reported to express all NMDAR subunits with different levels (https://
web.stanford.edu/group/barres_lab/brain_rnaseq.html). These expression levels in astrocytes 
are paired with expression levels in neurons for comparison and were reported in fragments 
per kilobase of transcript sequence per million mapped fragments (FPKM) as follows: GluN1 
(Grin1) astrocytes ≈3 vs. >60 neurons; GluN2A (Grin2a) ≈ 0.1 vs. ≈ 0.8; GluN2B (Grin2b) ≈ 0.6 vs. 
≈ 3; GluN2C (Grin2c) >25 vs. <1; GluN2D (Grin2d) <0.5 vs. ≈ 1.4; GluN3A (Grin3a) ≈ 5 vs. ≈ 6; 
GluN3B (Grin3b) ≈ 0.2 vs. ≈ 0.3. Thus, this study confirmed previous findings in other expres-
sion databases [110, 122] indicating GluN1, GluN2C, and GluN3A expression in tissue astro-
cytes but also found low expression levels of the other NMDAR subunits.
Later, Haustein et al. [125] studied spontaneous Ca2+ transients in mouse hippocampal astro-
cytes infected with an adenovirus containing the genetically encoded Ca2+ indicator (GECI) 
GCaMP. In this work, APV application did not significantly modify soma or projection spon-
taneous Ca2+ transient peak responses, amplitude, or kinetics. However, if traces of these 
experiments in the work by Haustein et al. [125] are conscientiously analyzed, some subtle 
differences are observed that perhaps could not be detected due to the statistical analysis 
or the population of peaks analyzed. However, if this could be true, the effect of APV was 
contrary to that described by Lalo et al. [105], because in this case, it appears as if NMDAR 
blockade increased spontaneous iCa2+ transients.
The following year, one of us published a work in which serendipitously a metabotropic-like 
Ca2+ flux–independent NMDAR was found in cultured rat cortical astrocytes [15]. In these cells, 
the expression of the seven NMDAR subunits was found at the mRNA and protein level by 
immunofluorescence and of GluN1 by WB. Interestingly, it was found that acid-NMDA (1 mM; 
pH 6.0) elicited iCa2+ responses in Fluo-4 labeled astrocytes that were not blocked by MK-801 
nor by Ca2+-free extracellular solution, but they were blocked by APV, KYNA, XesC, ryano-
dine (inhibitor of ryanodine receptors), or GluN1 knockdown by siRNA. Later, we found that 
iCa2+ response was elicited by the NMDAR but in response to acid pH that regulates NMDAR 
canonic function [2], rather than to NMDA itself. Also, acid-NMDA treatment depleted mito-
chondrial membrane potential (mΔψ). These results strongly suggested that cultured astro-
cytes express an NMDAR than generates Ca2+ release from IC pools, mediated by IP3R and 
ryanodine receptors as suggested earlier by Gerard and Hansson [121]. However, in contrast 
to their work, we ruled out that CICR was involved since MK-801 and extracellular Ca2+-free 
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solution did not block this response. These observations COULD help to explain the initial find-
ings in cultured astrocytes that reported no electrophysiological response to NMDA or no iCa2+ 
response to low concentrations of NMDA. Nevertheless, the molecular mechanisms that enable 
this noncanonical function of the NMDAR still remain to be investigated.
The same year, Jimenez-Blasco et al. [126] reported that in cultured rat cortical astrocytes they 
observed iCa2+ rise measured with Fura-2 elicited by NMDA (1–100 μM). Curiously, NMDA 
effect was delayed by 500–1000 s after its application, presumably due to the low permeabil-
ity of NMDAR in astrocytes. NMDA effect was partially sensitive to extracellular Ca2+-free 
solution, suggesting NMDAR canonical ionotropic function, but it was fully blocked by Ca2+-
free solution in combination with SERCA inhibition by thapsigargin, evidencing also Ca2+ 
release from IC pools, although CICR was not ruled out. Moreover, iCa2+ rise was sensitive to 
U73122, inhibitor of phospholipase C (PLC), suggesting that IP3 synthesis could be involved 
in this effect, in agreement with our results. In addition, long-term NMDA treatment (20 μM, 
8 h) promoted the activation of the PLC/protein kinase C (PKC)/p35/cyclin-dependent kinase 
(Cdk5) pathway that leads to nuclear factor erythroid 2-related factor 2 (Nrf2) activation and 
its nuclear accumulation, effect blocked by MK-801. Consistently, NMDA treatment activated 
the transcription of Nrf2-target genes.
Long-term effects of NMDA on astrocytes were reported also by Obara-Michlewska et al. 
[127], who tested the expression of inwardly rectifying K+ channels (Kir4.1). In these experi-
ments, the treatment of cultured rat astrocytes with NMDA (100 μM, 72 h) decreased the 
expression of Kir4.1 at the mRNA and protein level, effect reverted by MK-801 or APV. In 
addition, in a rat model of acute liver failure, memantine attenuated the decrease of Kir4.1 
mRNA in the rat cortex.
On the other hand, Morquette et al. [128] described a role of astrocytes in the rat central pattern 
generator of the dorsal part of the trigeminal main sensory nucleus. In this study, it was found 
that astrocytes in this nucleus presented membrane currents or iCa2+ rise elicited by electric 
stimulation or NMDA treatment (1–2 mM), while neuronal activity turned from tonic to burst-
ing and was also accompanied by iCa2+ rise. NMDA-elicited depolarizations in astrocytes were 
insensitive to TTX, whereas an inhibitory cocktail (CNQX, TTX, Cd2+, and L-trans-pyrollidine-
2,4-dicarboxylic acid [PCD] inhibitor of Glu uptake) blocked 53% of astrocyte response but 
almost fully blocked neuronal response, suggesting that astrocytic NMDAR was involved. Also, 
MK-801 diffused intracellularly in astrocytes blocked NMDA-elicited response in these cells. 
Together, these results strongly suggested that these astrocytes expressed functional NMDAR.
However, Otsu et al. [129] studied with the Ca2+ sensor Rhod-2 iCa2+ responses in glomerular 
astrocytes in the juvenile (14–21 day old) mouse olfactory bulb. In this work, it was found that 
electrical stimulation of odor sensory neurons elicited iCa2+ responses in glomerular astro-
cytes and neurons. Astrocyte responses were delayed and elicited only with high stimulus 
intensities in contrast to neuronal ones that were elicited even with single pulse stimulation. 
Astrocyte and neuronal responses were blocked by a combination of APV and CNQX, similar 
to the observations made by Lalo et al. [105] in cortical astrocytes. Nevertheless, considering 
the delay between both responses, these authors suggested that in astrocytes, responses were 
mediated by postsynaptic activity (dendrite Glu release), instead of a direct stimulation of 
Astrocyte - Physiology and Pathology70
astrocytic NMDAR or AMPAR. It must be noted that these observations were made measur-
ing somatic Ca2+ dynamics, but the NMDAR role was not tested when a GECI mouse model 
was used. This could be relevant because it has been shown that somatic and projection iCa2+ 
responses have different molecular players [125, 130, 131].
In this year also, Dzamba et al. [132] analyzed the expression of NMDAR subunits in cortical 
astrocytes from the EGFP-GFAP mouse before and after ischemia by single cell quantitative 
RT-PCR. In these experiments, all NMDAR subunits were expressed by astrocytes of uninjured 
mouse with the exception of GluN3B that presented in very low levels, consistently with their 
previous work [123]. The expression of these genes was increased 7 and 14 days after ischemia, 
with the exception of GluN2C that was the highest expressed subunit in control conditions and 
GluN3B that did not increase nor was detected. In contrast, immunofluorescence experiments 
in brain slices showed only GluN3A expression in control animals, but after ischemia, NMDAR 
subunits GluN1 and GluN2B-D were also observed. iCa2+ responses were elicited in tissue 
astrocytes by NMDA (4–100 mM), were not blocked by TTX, but were sensitive to APV and 
memantine. In contrast to previous findings, ischemia reduced iCa2+ responses to NMDA. Also, 
cortical cultured astrocyte iCa2+ responses were elicited, but with higher NMDA concentration 
(500 μM), these responses were also reduced in astrocytes isolated from ischemic mice.
An additional study [133] tested the effect of MK-801 in GFAP expression in tissue hippocam-
pal and cultured astrocytes from rat. In these experiments, MK-801 (6 days) increased GFAP 
expression in the hippocampus as measured by immunofluorescence and WB. Consistently, 
MK-801 (24 h) increased GFAP, BDNF, TrkB, and p75 expression at the mRNA and protein 
level in hippocampal cultured astrocytes. These results suggested that NMDAR activity 
mediates these effects in astrocytes. Moreover, with these results, the authors proposed that 
hippocampal astrocytes may participate in NMDAR hypofunction associated to the patho-
physiology of schizophrenia.
In 2016, one study by Pinacho et al. [134] showed that MK-801 upregulated the expression of 
glycogen phosphorylase (PYGM) and RAC-1 when administered in mice but also in cultured 
rat cortical astrocytes (72 h).
Recently, Mehina et al. [135] studied astrocytes in mouse cortical slices and found that neu-
ronal theta burst stimulation generated transient iCa2+ increase in astrocyte soma and projec-
tions, followed by a long-lasting decrease of cytoplasmic Ca2+ basal levels, perhaps related 
with observations made by Cornell-Bell et al. [80] with NMDA. Although the transient iCa2+ 
response in astrocytes was blunted by APV, this was not statistically significant; however, 
it did block the long-lasting decrease of cytoplasmic Ca2+ basal levels. Importantly, MK-801 
applied intracellularly by the patch pipette also blocked the long-lasting decrease of basal Ca2+, 
indicating that it was mediated by astrocytic NMDAR. Consistent with the role of NMDAR, it 
was also found that a NOS inhibitor mediated the decrease of basal Ca2+, probably through its 
regulation of SERCA. These authors also showed that basal Ca2+ levels in astrocytes regulate 
long-lasting vascular tone, effect blocked by APV.
All in all, these studies have substantiated that astrocytes do express NMDAR at the mRNA, 
protein, and functional level. However, the reach of this conclusion has not been easy because 
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apparent contradictory findings or controversies have been often reported. A critical issue 
through this achievement has been the distinction between neuronal and astrocytic NMDAR, 
considering their location at or near the synapse, but also presynaptic membranes, very close 
to the perisynaptic astrocyte projection (PAP), where the NMDAR may mediate astrocytic 
Ca2+ responses relevant for information handling in the brain. Nevertheless, other sites of 
NMDAR actions besides the PAP should not be discarded.
An additional source of controversy has been the selection of the experimental approach and 
model to test NMDAR in astrocytes. It seems clear now that canonical ionotropic NMDAR 
function is not conserved in cultured cells compared with tissue astrocytes. Classical electro-
physiological experiments initially set the basis to conceive the lack of NMDAR in cultured 
astrocytes. However, the same approaches applied to tissue or acute isolated astrocytes sug-
gested NMDAR function. In this regard, it is very interesting why and how the NMDAR 
becomes a different functional molecule when astrocytes are cultured and what may be the 
physiological relevance (if any) at the cellular and tissular level (see below).
An important source of controversy has been the a priori expectations that NMDAR in astrocytes 
should have similar biophysical and functional properties as its well-studied neuronal synap-
tic counterpart. Pharmacological studies have already demonstrated that NMDAR in astrocytes 
may be assembled by different subunits that confer particular functional properties. Its multisub-
unit nature, diversity of subunits, and multiple posttranslational and posttranscriptional modi-
fications suggest that NMDAR function is more complex as it goes beyond synaptic function. 
Interestingly, in line with this conception, some reports have already documented a noncanonical 
metabotropic-like, flux-independent NMDAR function in astrocytes but also in neurons [10–12, 
15]. Intriguingly, phosphatidylinositol metabolism was found associated with NMDAR-mediated 
Ca2+ flux in Muller and Bergman cells [136, 137]. As a matter of fact, metabotropic-like, flux- 
independent function is not necessarily new for ionotropic Glu receptors. It has been reviewed 
elsewhere that this kind of mechanisms occurs for kainate receptors, some of them described 
almost 2 decades ago [138]. However, the cellular and molecular mechanisms that make this pos-
sible are poorly studied and become very relevant considering NMDAR function in other cells 
and tissues and flux-independent function observed in neuronal-mediated mechanisms.
Some of the methodological and experimental sources of controversy that precluded the 
acknowledgment of NMDAR expression and function in astrocytes are shared with those 
that precluded the acceptance of astrocyte iCa2+ dynamic responses in CNS handling of infor-
mation and function. Please refer to the review by Khakh and McCarthy [139] who deeply 
discussed these aspects.
4. Insights regarding astrocytic NMDAR
Given the relevance of NMDAR in CNS, the expression of NMDAR in astrocytes, and its role 
in information handling in CNS, the intuitive conclusion is that NMDAR in astrocytes is impli-
cated in this function, as some electrophysiological works have already demonstrated, detect-
ing iCa2+ signals in response to synaptic activity. However, electrical activity in astrocytes may 
have a secondary role in comparison to other cellular activities such as for instance synctitial 
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 communication, in contrast with their neuronal counterparts. Therefore, it is convenient to 
take into account the diversity of Ca2+-dependent metabotropic IC signals elicited by NMDAR 
activation, outlined above, that could shape astrocyte activities. Since GluN2C is preferentially 
assembled into astrocytic NMDAR, then it is possible that IC pathways differ from GluN2A/B 
NMDAR, as some initial works have demonstrated. This is even more relevant when it is consid-
ered that astrocytes are involved not only in information handling, but also in energy adminis-
tration, immune response to infection or tissue damage, development, or synaptogenesis, among 
other functions [17, 140]. In this regard, the IC pathways activated by Ca2+ entry through the 
NMDAR must be critical for the long-term effects that could occur not only to the astrocyte but 
also to its syncytium. Indeed, as described above, some groups have already started to study 
these long-term effects in astrocytes after chronic exposure to NMDA, and as history has dem-
onstrated, cell culture is a useful tool to study these aspects. In addition, NMDAR has been 
shown to mediate IC signaling in astrocytes, function critically involved in neuronal survival. 
Furthermore, since astrocytes are also involved in the immune response and some evidences 
point to enhanced NMDAR activity in these cells after ischemia, thus it is possible to conceive 
that NMDAR in astrocytes is involved in immune function of these cells, as has been observed 
previously in lymphocytes [8]. Also, recent work has suggested that NMDAR of astrocytes could 
be involved in the hypofunction of NMDAR that has been proposed as an alternative hypothesis 
to understand schizophrenia [133]. More work is needed to investigate how NMDAR in astro-
cytes is related to other pathologies that have been related to astrocyte functions [141].
On the other hand, Ca2+ flux–independent metabotropic signaling by NMDAR in cultured astro-
cytes provides the grounds for a new framework of NMDAR activity, although more research 
is required to further confirm its occurrence in tissue astrocytes. Nevertheless, it must be noted 
that multifunctionality of cell membrane molecules is now well documented, and most of these 
mechanisms were initially described in cultured cells ([136]; and references therein). Indeed, it 
is possible that the effect observed by Nishizaki et al. [97] and Kondoh et al. [101] in cultured 
human astrocytes with a G-protein inhibitor could be related to NMDAR signaling inhibition 
itself instead of NMDA activation of an unknown receptor that elicited G-protein activation, or 
NMDAR regulation by a GPCR, as it was suggested. If true, this report could be the first hint-
ing Ca2+ flux–independent metabotropic signaling by NMDAR. Therefore, this kind of signal-
ing should not be discarded a priori, also considering that this Ca2+ flux–independent NMDAR 
function has also been observed in neuronal-mediated responses, and the number of works 
documenting this function is increasing [12, 142]. Moreover, flux-independent metabotropic 
signaling by other ionotropic Glu receptors have been known for almost 2 decades [138].
The experimental evidence indicates that in cultured astrocytes Ca2+ flux–independent 
metabotropic NMDAR signaling is dominant over its ionotropic function, that could be exac-
erbated by culture conditions, such as Glu concentration or the extracellular proteins present 
in fetal bovine serum. However, it is not possible to rule out that in tissue astrocytes some 
NMDAR, probably distributed at specific cellular locations, may elicit this kind of signaling. 
The currents observed in acute isolated astrocytes, the conservation of some classical iono-
tropic NMDAR function in astrocytes cocultured with endothelial cells, and its absence in 
pure cultured astrocytes support this notion [15, 105, 121], because cellular interactions may 
be involved in the conservation of canonical NMDAR function. Moreover, these observations 
may reflect a gradual conversion of NMDAR function due to some unknown mechanism that 
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may be related to membrane dynamics. In addition, our observations suggest that there is 
some sort of segregation of Ca2+ flux–dependent and –independent functions of NMDAR in 
cultured astrocytes [143, 144]. Consistent with these putative Ca2+ flux–dependent and –inde-
pendent functions of NMDAR, long-term effects in cultured astrocytes and even iCa2+ rise in 
human cultured astrocytes have been blocked by MK-801 or memantine, thus substantiating a 
canonical ionotropic function. This somehow contradicts the fact that most electrophysiologi-
cal recordings in cultured astrocytes have never found NMDAR-mediated currents, with the 
exception of the work with human astrocytes from the white matter that intriguingly were not 
sensitive to APV. These apparent contradictions may have their source in the experimental 
settings employed, as described above. For instance, the cell model employed may cooperate 
in this variability given the diversity of astrocytes [145, 146]. Also, the intracellular crosstalk 
among Glu ionotropic and metabotropic receptors and their regulation in the experimental 
models employed may interplay and result in the apparent contradictions observed. In addi-
tion, it is of note that most experiments studying NMDAR in cultured astrocytes have used 
high agonist concentrations that are within the Glu concentration reached in the synaptic cleft 
after neurotransmission [147]. Also, it is interesting that different physiological solutions have 
been used with cultured astrocytes that could be related to the observations made. Notably, 
experiments with human astrocytes have shown unique behaviors of NMDAR suggesting per-
haps that in human cells NMDAR may have specific molecular features that are still unknown.
However, the fact that cultured rat astrocytes present Ca2+ flux–independent metabotropic 
NMDAR signaling indicates at least the existence of a cellular and/or molecular mechanism 
that enables this function, although it could be overrepresented in cultured astrocytes due to 
culture conditions. This mechanism may be related to the expression of genes that let some 
authors conclude that cultured astrocytes represent an undifferentiated or activated pheno-
type of astrocytes. Nonetheless, since NMDAR is also expressed by endothelial cells, leuko-
cytes, osteoblasts, platelets, or melanocytes, among other cells but also in a diversity of tissues 
including stomach, testis, thymus, ovaries, skin, pancreas, lung, kidney, or heart [3], it is likely 
that NMDAR function may encompass other mechanisms of action and regulation, beyond 
those described for synaptic or extrasynaptic NMDAR. For instance, leukocytes or endothelial 
cells are in contact with 40 times higher Glu (40 μM) in the blood than cells of CNS bathed by 
the cerebrospinal fluid (1 μM) [148]. Therefore, NMDAR in these cells must require particu-
lar cellular or molecular mechanisms to avoid its activation and the resulting entry of large 
quantities of Ca2 that could activate them or even be cytotoxic. Also, Mg2+ blockade should 
not work in these cells since Glu concentrations are constant, unless it is regulated differently 
to neuronal NMDAR. One alternative for this Ca2+ flux–independent metabotropic-like func-
tion is that in cell culture, the NMDAR associates with molecular partners that enable this 
function. Interestingly, it has been reported that NMDAR has been found to associate with 
metabotropic dopamine receptors [149]. There is also a possibility that Ca2+ flux– independent 
metabotropic-like NMDAR function could be the result of proteolytic cleavage, as that already 
reported for NMDAR subunit GluN1 [150], that occurs to other membrane molecules [151]. In 
addition, GluN2C subunit–mediated IC signaling, found highly expressed in most transcrip-
tome analysis of astrocytes, but that has been poorly studied, could be involved.
Of particular interest is the fact that, according to our results, higher H+ concentration seems 
responsible to elicit NMDAR Ca2+ flux–independent metabotropic-like function. This is because 
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three main points are relevant for CNS: (a) It is well known that presynaptic Glu release causes 
an increase of H+ concentration in the synaptic cleft [152]. (b) Under certain processes such as 
inflammation, hypoxia/ischemia, or hypercapnia, among others, very low pH levels may be 
reached in the brain [153]. (c) The NMDAR is well known to be regulated negatively by acidic 
pH, and the amino acid sequences that mediate this effect have been identified [2]. Then, Ca2+ 
flux–independent metabotropic-like function of NMDAR in astrocytes presents singularities, 
or even antagonic features when compared with canonical NMDAR that could be relevant for 
astrocyte function and therefore for the maintenance of brain homeostasis. Thus, the study of 
the molecular mechanisms that make possible Ca2+ flux–independent function of the NMDAR 
may open new possibilities to modulate NMDAR function in certain pathologies.
On the other hand, which advantage presents the Ca2+ flux–independent metabotropic-like 
NMDAR in astrocytes? Perhaps the easiest answer is that some sort of NMDAR signaling could 
be initiated without extracellular Ca2+ entry that could pose a menace for cellular homeostasis. 
This could be more advantageous if it is considered that in our experiments we found that Ca2+ 
flux–independent metabotropic-like NMDAR is dependent on H+ levels above physiological 
normal levels [15]. However, the nature of the IC pathways initiated by this Ca2+ flux–indepen-
dent metabotropic-like NMDAR still remains to be investigated, because the PLC/PKC/p35/
Cdk5/Nrf2 pathway activation was sensitive to MK-801 similar to CAPON nuclear translocation 
that may lead to MAPK activation through NOS. Thus, it seems that activation of these path-
ways by long-term treatment with NMDA requires Ca2+ flux. To further analyze this question, 
it is then necessary to define whether this metabotropic-like function is mediated by a channel 
NMDAR with posttranslational modifications that is also capable to initiate signal transduc-
tion as has been observed in neuronal NMDAR [12, 142] or by a nonchannel NMDAR. In the 
first case then, some specific mechanism of channel blockade must act to avoid fast measurable 
Ca2+ flux through NMDAR. In the second case, perhaps other molecular mechanisms could 
result in a nonchannel NMDAR, as described above. However, this question requires further 
research to fully understand the mechanism that enables Ca2+ flux– independent metabotropic-
like NMDAR in astrocytes and perhaps in neurons or other cell types.
All the above-described effects mediated by NMDAR in astrocytes must occur when it is 
located in (a) the astrocyte synaptic membrane (AsSm) of the PAP that directly contacts the 
synapse, analog to the postsynaptic membrane, and/or in (b) PAP extrasynaptic sites that 
could even include the soma. However, IHC-EM experiments have indicated that NMDAR 
in astrocytes is preferentially located in their projections. In addition, Lalo et al. [105] have 
already described the GSC, suggesting that Glu sensing takes place at the PAP or near it, 
thus somatic NMDAR function seems unlikely, although this needs to be tested. The PAP is 
a dynamic structure that surrounds the synaptic bouton (Figure 3) extending and retracting 
as a function of synaptic activity. The more neuronal activity, the more neurotransmitter and 
the more PAP coverage [125, 154, 155]. But, is the NMDAR present in the AsSm of PAPs? Or is 
NMDAR located in extrasynaptic sites in the PAP where it would only be activated by some 
Glu spillover? If it is located in AsSm, then NMDAR could be sensing tiny amounts of Glu, 
whereas if it is in extrasynaptic sites, then only high synaptic activity would lead to its activa-
tion. This is in fact a common feature of iCa2+ signaling in astrocytes, and it is observed with 
high synaptic activity, as described by different groups [105, 125]. However, this observation 
could be the result of the integration of synaptic activity carried out by astrocytes and thus 
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does not necessarily rule out the presence of NMDAR in front of the synapse. Instead, it is pos-
sible that not enough receptors located at the AsSm are activated when low synaptic activity is 
elicited and thus the whole cell currents are not recorded. Therefore, at this point, it is not clear 
the exact location of astrocytic NMDAR; however, in this context, the density and organiza-
tion of receptors at cell membrane in either location are relevant for the final result (Figure 3).
At this point, it is convenient to recall that Glu has been suggested to exert only metabotropic 
signaling (through mGluR, although the putative Ca2+ flux–independent function of NMDAR 
could participate) in extrasynaptic sites of the PAP, in view of the location of IC Ca2+ stores ≈1 μm 
far from the AsSm [156]. However, according to our biophysical modeling work, Ca2+ and IP3 
diffusion coefficients (10X larger for IP3), together with mGluR location, support that synaptic 
astrocyte Glu metabotropic signaling may occur and reach IC Ca2+ stores within millisecond time 
scales depending upon PLC activity and number [157]. Moreover, PAP leaf-like morphology 
would optimize IP3 straightforward diffusion to IC Ca2+ stores. In contrast, although Glu has 
a ≈ 1.5 faster diffusion coefficient than IP3, the need to escape from the synaptic cleft and over-
ride the PAP enwrapping in the EC space and Glu multidirectional diffusion would perhaps 
make this alternative more difficult to occur, although not impossible when very high Glu 
secretion is reached (Figure 3).
Considering the ambivalent nature of NMDAR signaling described above (synaptic vs. 
extrasynaptic), an additional immediate question that comes up is which kind of signaling 
(prosurvival or prodeath) results from astrocytic NMDAR? Since astrocytes are resistant to 
Figure 3. Astrocytic NMDAR putative locations. NMDAR may be located in the astrocyte synaptic membrane (AsSm) 
and/or astrocytic extrasynaptic membranes. IC signaling (a or b) in both places could be specific, b requiring Glu spillover. 
In a and/or b, the Ca2+ flux–independent metabotropic-like NMDAR could be involved, reaching IC Ca2+ pools such as 
the ER in the PAP. As, astrocyte; PreSynN, presynaptic neuron; PosSynN, postsynaptic neuron (see text for details).
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different insults including high levels of Glu, then intuitively the answer should be prosur-
vival signaling. In fact, this has been confirmed by different works, but with some differences 
in comparison with synaptic NMDAR signaling described above. Activation of PLC/PKC/
p35/Cdk5/Nrf2, a prosurvival pathway, and CAPON nuclear translocation were described in 
cultured astrocytes in response to NMDAR [114, 126]. On the other hand, MK-801 treatment 
of cultured astrocytes upregulated glycogen phosphorylase and regulated the expression of 
growth and metabolic genes [134]. Together, these observations indicate that NMDAR in cul-
tured astrocytes provide signaling that help to maintain homeostasis. In line with this idea, 
ischemia increases NMDAR subunits, perhaps providing better tools for cell survival.
5. Conclusions
Research regarding NMDAR expression and function in astrocytes has been full of apparent 
contradictions and controversies and some of them still remain puzzling. Nevertheless, it now 
seems clear that tissue astrocytes do express NMDAR subunits that are assembled into func-
tional receptors that mediate membrane currents, but are different from the well-studied neu-
ronal NMDAR. On the other hand, cultured astrocytes also express NMDAR subunits, but it is 
well documented that NMDAR ligands do not elicit recordable membrane currents. However, 
few groups have found that NMDAR in cultured astrocytes evoke Ca2+ flux–independent 
metabotropic-like signaling, with the exception of human cultured astrocytes in which cur-
rents present certain singularities. Intriguingly, some reports have documented that long-term 
effects of NMDAR agonists in cultured astrocytes are prevented by the pore blocker MK-801. 
Thus, more research is needed to elucidate NMDAR function and its consequences in cultured 
astrocytes. Although NMDAR function in cultured astrocytes may represent a rare phenom-
ena that result from culture conditions, it cannot be discarded a priori that it may occur in tissue 
astrocytes. This possibility is supported by NMDAR wide expression in non-CNS cells that 
could also be relevant for NMDAR Ca2+ flux–independent effects also observed in neurons.
Moreover, the apparent contradictions and controversies found in the last decades in the study 
of NMDAR in astrocytes together with its wide expression in cells and tissues let us realize that 
the biology of NMDAR is much more complex than that described for synaptic NMDAR. This 
seems to be true even within the synapse, where presynaptic NMDAR has casted new com-
plexities in its synaptic function. Also, the NMDAR subunit phylogenetic conservation rein-
forces this idea. However, the understanding of NMDAR function in astrocytes and other cells 
and tissues may lead to envision new therapeutic strategies as has been suggested previously.
Acknowledgements
PMOB wishes to thank the invitation from Dr. Maria Teresa Gentile and Dr. Luca Colucci 
D’Amato to collaborate as an author in this book. PMOB also deeply thanks his family who 
has supported him despite the lack of funding and the difficulties to do science in his institu-
tion and our country. JRGH appreciates the unconditional support of his family and PMOB 
support and invitation to participate in this review.




Pavel Montes de Oca Balderas* and José Roberto González Hernández
*Address all correspondence to: pavel73@hotmail.com
Unit of Dynamic Neurobiology, Department of Neurochemistry, Instituto Nacional de 
Neurología y Neurocirugía, Mexico
References
[1] Paoletti P, Bellone C, Zhou Q. NMDA receptor subunit diversity: Impact on receptor prop-
erties, synaptic plasticity and disease. Nature Reviews. Neuroscience. 2013;14:383-400
[2] Traynelis SF, Wollmuth LP, McBain CJ, Menniti FS, Vance KM, Ogden KK, et al. Gluta-
mate receptor ion channels: Structure, regulation, and function. Pharmacological Reviews. 
2010;62:405-496
[3] Hogan-Cann AD, Anderson CM. Physiological roles of non-neuronal NMDA receptors. 
Trends in Pharmacological Sciences. 2016;37:750-767. DOI: 10.1016/j.tips.2016.05.012
[4] Aarts MM, Tymianski M. Novel treatment of excitotoxicity: Targeted disruption of 
intracellular signalling from glutamate receptors. Biochemical Pharmacology. 2003;66: 
877-886
[5] Hardingham GE, Bading H. Synaptic versus extrasynaptic NMDA receptor signalling: 
Implications for neurodegenerative disorders. Nature Reviews. Neuroscience. 2010;11: 
682-696
[6] Schwarzschild MA, Cole RL, Meyers MA, Hyman SE. Contrasting calcium dependen-
cies of SAPK and ERK activations by glutamate in cultured striatal neurons. Journal of 
Neurochemistry. 1999;72:2248-2255. DOI: 10.1046/j.1471-4159.1999.0722248.x
[7] Kalev-Zylinska ML, Green TN, Morel-Kopp MC, Sun PP, Park YE, Lasham A, et al. 
N-methyl-D-aspartate receptors amplify activation and aggregation of human platelets. 
Thrombosis Research. 2014;133:837-847
[8] Lombardi G, Dianzani C, Miglio G, Canonico PL, Fantozzi R. Characterization of iono-
tropic glutamate receptors in human lymphocytes. British Journal of Pharmacology. 
2001;133:936-944
[9] Spencer GJ, McGrath CJ, Genever PG. Current perspectives on NMDA-type glutamate 
signalling in bone. The International Journal of Biochemistry & Cell Biology. 2007;39: 
1089-1104
[10] Kessels HW, Nabavi S, Malinow R. Metabotropic NMDA receptor function is required 
for beta-amyloid-induced synaptic depression. Proceedings of the National Academy of 
Sciences of the United States of America. 2013;110:4033-4038
Astrocyte - Physiology and Pathology78
[11] Nabavi S, Fox R, Alfonso S, Aow J, Malinow R. GluA1 trafficking and metabotropic 
NMDA: Addressing results from other laboratories inconsistent with ours. Philosophical 
Transactions of the Royal Society B: Biological Sciences. 2013;369:20130145
[12] Dore K, Aow J, Malinow R. The emergence of NMDA receptor metabotropic function: 
Insights from imaging. Frontiers in Synaptic Neuroscience. 2016;8:1-9. DOI: 10.3389/
fnsyn.2016.00020
[13] Weilinger NL, Lohman AW, Rakai BD, Ma EMM, Bialecki J, Maslieieva V, et al. Metabo-
tropic NMDA receptor signaling couples Src family kinases to pannexin-1 during exci-
totoxicity. Nature Neuroscience. 2016;19:432-442. DOI: 10.1038/nn.4236
[14] Vissel B, Krupp JJ, Heinemann SF, Westbrook GL. A use-dependent tyrosine dephos-
phorylation of NMDA receptors is independent of ion flux. Nature Neuroscience. 2001; 
4:587-596
[15] Montes de Oca Balderas P, Aguilera P. A metabotropic-like flux-independent NMDA 
receptor regulates Ca2+ exit from endoplasmic reticulum and mitochondrial membrane 
potential in cultured astrocytes. PLoS One. 2015;10:e0126314. DOI: 10.1371/journal.
pone.0126314
[16] Araque A, Parpura V, Sanzgiri RP, Haydon PG. Tripartite synapses: Glia, the unac-
knowledged partner. Trends in Neurosciences. 1999;22:208-215
[17] Verkhratsky A, Butt AM, editors. Glial Physiology and Pathophysiology: A Handbook. 
1st ed. Chichester: Wiley-Blackwell; 2013
[18] Haddad JJ. N-methyl-D-aspartate (NMDA) and the regulation of mitogen-activated pro-
tein kinase (MAPK) signaling pathways: A revolving neurochemical axis for therapeu-
tic intervention? Progress in Neurobiology. 2005;77:252-282. DOI: 10.1016/j.pneurobio. 
2005.10.008
[19] Pláteník J, Kuramoto N, Yoneda Y. Molecular mechanisms associated with long-term 
consolidation of the NMDA signals. Life Sciences. 2000;67:335-364. DOI: 10.1016/S0024- 
3205(00)00632-9
[20] Hardingham GE, Fukunaga Y, Bading H. Extrasynaptic NMDARs oppose synaptic 
NMDARs by triggering CREB shut-off and cell death pathways. Nature Neuroscience. 
2002. DOI: 10.1038/nn835
[21] Sava A, Formaggio E, Carignani C, Andreetta F, Bettini E, Griffante C. NMDA-induced 
ERK signalling is mediated by NR2B subunit in rat cortical neurons and switches 
from positive to negative depending on stage of development. Neuropharmacology. 
2012;62:925-932. DOI: 10.1016/j.neuropharm.2011.09.025
[22] Waxman EA, Lynch DR. N-methyl-D-aspartate receptor subtypes: Multiple roles in 
excitotoxicity and neurological disease. The Neuroscientist. 2005;11:37-49. DOI: 10.1177/ 
1073858404269012
[23] Zhang SJ, Steijaert MN, Lau D, Schütz G, Delucinge-Vivier C, Descombes P, et al. 
Decoding NMDA receptor signaling: Identification of genomic programs specifying neu-
ronal survival and death. Neuron. 2007;53:549-562. DOI: 10.1016/j.neuron.2007.01.025
NMDA Receptors in Astroglia: Chronology, Controversies, and Contradictions from a Complex Molecule
http://dx.doi.org/10.5772/intechopen.72975
79
[24] Tovar KR, Westbrook GL. Mobile NMDA receptors at hippocampal synapses. Neuron. 
2002;34:255-264. DOI: 10.1016/S0896-6273(02)00658-X
[25] Zhou X, Ding Q, Chen Z, Yun H, Wang H. Involvement of the GluN2A and GluN2B 
subunits in synaptic and extrasynaptic N-methyl-D-aspartate receptor function and 
neuronal excitotoxicity. The Journal of Biological Chemistry. 2013;288:24151-24159. DOI: 
10.1074/jbc.M113.482000
[26] Xia Z, Storm DR. The role of Calmodulin as a signal integrator for synaptic plasticity. 
Nature Reviews. Neuroscience. 2005;6:267-276. DOI: 10.1038/nrn1647
[27] Malenka RC, Kauer JA, Perkel DJ, Mauk MD, Kelly PT, Nicoll RA, et al. And protein 
kinase activity an essential role for postsynaptic Calmodulin in long-term potentiation. 
Nature. 1989;340:554-557. DOI: 10.1038/340301a0
[28] Bading H, Ginty D, Greenberg M. Regulation of gene expression in hippocampal 
neurons by distinct calcium signaling pathways. Science (80-). 1993;260:181-187. DOI: 
10.1017/CBO9781107415324.004
[29] Ehlers MD, Zhang S, Bernhardt JP, Huganir RL. Inactivation of NMDA receptors by 
direct interaction of Calmodulin with the NR1 subunit. Cell. 1996;84:745-755. DOI: 10. 
1016/S0092-8674(00)81052-1
[30] Bayer K-U, De Koninck P, Leonard AS, Hell JW, Schulman H. Interaction with the 
NMDA receptor locks CaMKII in an active conformation. Nature. 2001;411:801-805. 
DOI: 10.1038/35081080
[31] Lisman J, Yasuda R, Raghavachari S. Mechanisms of CaMKII action in log term potentia-
tion. Nature Reviews. Neuroscience. 2012;13:169-182. DOI: 10.1002/ana.22528.Toll-like
[32] Engert F, Bonhoeffer T. Dendritic spine changes associated with hippocampal long-term 
synaptic plasticity. Nature. 1999;399:66-70
[33] Hardingham GE, Arnold FJ, Bading H. Nuclear calcium signaling controls CREB-
mediated gene expression triggered by synaptic activity. Nature Neuroscience. 2001;4: 
261-267. DOI: 10.1038/85109
[34] Coultrap SJ, Bayer KU. CaMKII regulation in information processing and storage. Trends 
in Neurosciences. 2012;35:607-618. DOI: 10.1016/j.tins.2012.05.003
[35] Impey S, Fong AL, Wang Y, Cardinaux JR, Fass DM, Obrietan K, et al. Phosphorylation of 
CBP mediates transcriptional activation by neural activity and CaM kinase IV. Neuron. 
2002;34:235-244. DOI: 10.1016/S0896-6273(02)00654-2
[36] Shi G-X, Andres DA, Cai W. Ras family small GTP-ase-mediated neuroprotective signal-
ing in stroke. Central Nervous System Agents in Medicinal Chemistry. 2011;11:114-137. 
DOI: 10.1002/ana.22528.Toll-like
[37] Bading H, Greenberg ME. Stimulation of protein tyrosine phosphorylation by NMDA 
receptor activation. Science (New York, NY). 1991;253:912-914. DOI: 10.1126/science. 
1715095
Astrocyte - Physiology and Pathology80
[38] Yun HY, Gonzalez-Zulueta M, Dawson VL, Dawson TM. Nitric oxide mediates N-methyl-
D-aspartate receptor-induced activation of p21 ras. Proceedings of the National Academy 
of Sciences of the United States of America. 1998;95:5773-5778
[39] Weissman BA, Jones CL, Liu Q, Gross SS. Activation and inactivation of neuronal 
nitric oxide synthase: Characterization of Ca2+-dependent [125I] Calmodulin binding. 
European Journal of Pharmacology. 2002;435:9-18. DOI: 10.1016/S0014-2999(01)01560-6
[40] Krapivinsky G, Krapivinsky L, Manasian Y, Ivanov A, Tyzio R, Pellegrino C, et al. The 
NMDA receptor is coupled to the ERK pathway by a direct interaction between NR2B 
and RasGRF1. Neuron. 2003;40:775-784. DOI: 10.1016/S0896-6273(03)00645-7
[41] Fan X, Jin WY, Wang YT. The NMDA receptor complex: A multifunctional machine at 
the glutamatergic synapse. Frontiers in Cellular Neuroscience. 2014;8:160. DOI: 10.3389/
fncel.2014.00160
[42] Joyal JL, Burks DJ, Pons S, Matter WF, Vlahos CJ, White MF, et al. Calmodulin activates 
phosphatidylinositol 3-kinase. The Journal of Biological Chemistry. 1997;272:28183-
28186. DOI: 10.1074/jbc.272.45.28183
[43] Chandler LJ, Sutton G, Dorairaj NR, Norwood D. N-methyl-D-aspartate receptor-medi-
ated bidirectional control of extracellular signal-regulated kinase activity in cortical neu-
ronal cultures. The Journal of Biological Chemistry. 2001;276:2627-2636. DOI: 10.1074/
jbc.M003390200
[44] Sutton G, Chandler LJ. Activity-dependent NMDA receptor-mediated activation of pro-
tein kinase B/Akt in cortical neuronal cultures. Journal of Neurochemistry. 2002;82:1097-
1105. DOI: 10.1046/j.1471-4159.2002.01031.x
[45] Hay N, Sonenberg N. Upstream and downstream of ran GTPase. Genes & Development. 
2004;18:1926-1945. DOI: 10.1515/BC.2000.052
[46] Kovacs KA, Steullet P, Steinmann M, Do KQ, Magistretti PJ, Halfon O, et al. TORC1 is a 
calcium- and cAMP-sensitive coincidence detector involved in hippocampal long-term 
synaptic plasticity. Proceedings of the National Academy of Sciences. 2007;104:4700-
4705. DOI: 10.1073/pnas.0607524104
[47] Sasaki T, Takemori H, Yagita Y, Terasaki Y, Uebi T, Horike N, et al. SIK2 is a key regulator 
for neuronal survival after ischemia via TORC1-CREB. Neuron. 2011;69:106-119. DOI: 
10.1016/j.neuron.2010.12.004
[48] Zhang S-J, Buchthal B, Lau D, Hayer S, Dick O, Schwaninger M, et al. A signaling Cascade 
of nuclear calcium-CREB-ATF3 activated by synaptic NMDA receptors defines a gene 
repression module that protects against extrasynaptic NMDA receptor-induced neuro-
nal cell death and ischemic brain damage. The Journal of Neuroscience. 2011;31:4978-
4990. DOI: 10.1523/JNEUROSCI.2672-10.2011
[49] Tolias KF, Bikoff JB, Burette A, Paradis S, Harrar D, Tavazoie S, et al. The Rac1-GEF 
Tiam1 couples the NMDA receptor to the activity-dependent development of dendritic 
arbors and spines. Neuron. 2005;45:525-538. DOI: 10.1016/j.neuron.2005.01.024
NMDA Receptors in Astroglia: Chronology, Controversies, and Contradictions from a Complex Molecule
http://dx.doi.org/10.5772/intechopen.72975
81
[50] Fleming IN, Elliott CM, Buchanan G, Downes CP, Exton H, Buchanan FG, et al. Ca2+/
Calmodulin-dependent protein kinase II regulates Tiam1 by reversible protein phos-
phorylation. The Journal of Biological Chemistry. 1999;274:12753-12758
[51] Lieberman DN, Mody I. Regulation of NMDA channel function by endogenous Ca2+-
dependent phosphatese. Nature. 1994;369:235-239
[52] Fukazawa Y, Saitoh Y, Ozawa F, Ohta Y, Mizuno K, Inokuchi K. Hippocampal LTP is 
accompanied by enhanced F-actin content within the dendritic spine that is essential for late 
LTP maintenance in vivo. Neuron. 2003;38:447-460. DOI: 10.1016/S0896-6273(03)00206-X
[53] Xia Z, Dudek H, Miranti CK, Greenberg ME. Calcium influx via the NMDA receptor 
induces immediate early gene transcription by a MAP kinase/ERK-dependent mecha-
nism. The Journal of Neuroscience. 1996;16:5425-5436
[54] Lau D, Bading H. Synaptic activity-mediated suppression of p53 and induction of 
nuclear calcium-regulated Neuroprotective genes promote survival through inhibition 
of mitochondrial permeability transition. The Journal of Neuroscience. 2009;29:4420-
4429. DOI: 10.1523/JNEUROSCI.0802-09.2009
[55] Leveille F, Papadia S, Fricker M, Bell KFS, Soriano FX, Martel M-A, et al. Suppression 
of the intrinsic apoptosis pathway by synaptic activity. The Journal of Neuroscience. 
2010;30:2623-2635. DOI: 10.1523/JNEUROSCI.5115-09.2010
[56] Riedl SJ, Salvesen GS. The apoptosome: Signalling platform of cell death. Nature 
Reviews. Molecular Cell Biology. 2007;8:405-413. DOI: 10.1038/nrm2153
[57] Ivanov A, Pellegrino C, Rama S, Dumalska I, Salyha Y, Ben-Ari Y, et al. Opposing role 
of synaptic and extrasynaptic NMDA receptors in regulation of the extracellular signal-
regulated kinases (ERK) activity in cultured rat hippocampal neurons. The Journal of 
Physiology. 2006;572:789-798. DOI: 10.1113/jphysiol.2006.105510
[58] Myung JK, Dunah AW, Yu TW, Sheng M. Differential roles of NR2A- and NR2B-
containing NMDA receptors in Ras-ERK signaling and AMPA receptor trafficking. 
Neuron. 2005;46:745-760. DOI: 10.1016/j.neuron.2005.04.031
[59] Chen HJ, Rojas-Soto M, Oguni A, Kennedy MB. A synaptic Ras-GTPase activating pro-
tein (p135 SynGAP) inhibited by CaM kinase II. Neuron. 1998;20:895-904. DOI: 10.1016/
S0896-6273(00)80471-7
[60] Salih DAM, Brunet A. FoxO transcription factors in the maintenance of cellular homeo-
stasis during aging. Current Opinion in Cell Biology. 2008;20:126-136. DOI: 10.1016/j.
ceb.2008.02.005.FoxO
[61] Al-Mubarak B, Soriano FX, Hardingham GE. Synaptic NMDAR activity suppresses 
FOXO1 expression via a cis-acting FOXO binding site: FOXO1 is a FOXO target gene. 
Channels. 2009;3:233-238. DOI: 10.1038/nn2071.Al-Mubarak
[62] Dick O, Bading H. Synaptic activity and nuclear calcium signaling protect hippocam-
pal neurons from death signal-associated nuclear translocation of FoxO3a induced by 
extrasynaptic N-methyl-D-aspartate receptors. The Journal of Biological Chemistry. 
2010;285:19354-19361. DOI: 10.1074/jbc.M110.127654
Astrocyte - Physiology and Pathology82
[63] Dieterich DC, Karpova A, Mikhaylova M, Zdobnova I, König I, Landwehr M, et al. 
Caldendrin-Jacob: A protein liaison that couples NMDA receptor signalling to the 
nucleus. PLoS Biology. 2008;6:0286-0306. DOI: 10.1371/journal.pbio.0060034
[64] Liu J, Liu MC, Wang KKW. Calpain in the CNS: from synaptic function to neurotoxicity. 
Science Signaling. 2008;1:re1. DOI: 10.1126/stke.114re1
[65] Xu J, Kurup P, Zhang Y, Goebel-goody SM, Wu PH, Hawasli AH, et al. Extrasynaptic 
NMDAR couple preferentially to excitotoxicity via calpain-mediated cleavage of STEP. 
The Journal of Neuroscience. 2009;2929:9330-9343. DOI: 10.1523/JNEUROSCI.2212-09. 
2009.Extrasynaptic
[66] Nguyen TH, Paul S, Xu Y, Gurd JW, Lombroso PJ. Calcium-dependent cleavage of 
striatal enriched tyrosine phosphatase (STEP). Journal of Neurochemistry. 1999;73: 
1995-2001
[67] Gurd JW, Bissoon N, Nguyen TH, Lombroso PJ, Rider CC, Beesley PW, et al. Hypoxia-
ischemia in perinatal rat brain induces the formation of a low molecular weight isoform 
of striatal enriched tyrosine phosphatase (STEP). Journal of Neurochemistry. 1999;73: 
1990-1994
[68] Kawasaki H, Morooka T, Shimohama S, Kimura J, Hirano T, Gotoh Y, et al. Activation and 
involvement of p38 mitogen-activated protein kinase in glutamate-induced apoptosis in 
rat cerebellar granule cells. The Journal of Biological Chemistry. 1997;272:18518-18521
[69] Verkhratsky A, Kirchhoff F. NMDA receptors in glia. The Neuroscientist. 2007;13:28-37
[70] Dzamba D, Honsa P, Anderova M. NMDA receptors in glial cells: Pending questions. 
Current Neuropharmacology. 2013;11:250-262. DOI: 10.2174/1570159X11311030002
[71] Krnjevic K, Schwartz S. Some properties of unresponsive cells in the cerebral cortex. 
Experimental Brain Research. 1967;3:306-319
[72] Hösli L, Andrés PF, Hösli E. Depolarization of cultured astrocytes by glutamate and 
aspartate. Neuroscience. 1979;4:1593-1598. DOI: 10.1016/0306-4522(79)90022-8
[73] Constanti A, Galvan M. Amino acid-evoked depolarization of electrically inexcitable 
(neuroglial?) cells in the guinea pig olfactory cortex slice. Brain Research. 1978;153:183-187
[74] Kettenmann H, Schachner M. Pharmacological properties of gamma-aminobutyric acid-, 
glutamate-, and aspartate-induced depolarizations in cultured astrocytes. The Journal of 
Neuroscience. 1985;5:3295-3301
[75] Bowman CL, Kimelberg HK. Excitatory amino acids directly depolarize rat brain astro-
cytes in primary culture. Nature. 1984;311:656-659
[76] Sontheimer H, Kettenmann H, Backus KH, Schachner M. Glutamate opens Na+/K+ chan-
nels in cultured astrocytes. Glia. 1988;1:328-336. DOI: 10.1002/glia.440010505
[77] Pearce B, Albrecht J, Morrow C, Murphy S. Astrocyte glutamate receptor activation 
promotes inositol phospholipid turnover and calcium flux. Neuroscience Letters. 
1986;72:335-340. DOI: 10.1016/0304-3940(86)90537-9
NMDA Receptors in Astroglia: Chronology, Controversies, and Contradictions from a Complex Molecule
http://dx.doi.org/10.5772/intechopen.72975
83
[78] Usowicz MM, Gallo V, Cull-Candy SG. Multiple conductance channels in type-2 cerebel-
lar astrocytes activated by excitatory amino acids. Nature. 1989;339:380-383. DOI: 10.1038/ 
340301a0
[79] Backus K, Kettenmann H, Schachner M. Pharmacological characterization of the gluta-
mate receptor in cultured astrocytes. Journal of Neuroscience Research. 1989;282:274-282
[80] Cornell-Bell AH, Finkbeiner SM, Cooper MS, Smith SJ. Glutamate induces calcium waves 
in cultured astrocytes: Long-range glial signaling. Science (80-). 1990;247:470-473
[81] Jensen AM, Chiu SY. Fluorescence measurement of changes in intracellular calcium 
induced by excitatory amino acids in cultured cortical astrocytes. The Journal of Neuro-
science. 1990;10:1165-1175
[82] Cornell-Bell AH, Thomas PG, Smith SJ. The excitatory neurotransmitter glutamate causes 
filopodia formation in cultured hippocampal astrocytes. Glia. 1990;3:322-334
[83] Dani JW, Chernavsky A, Smith SJ. Neuronal activity triggers calcium waves in hippo-
campal astrocytic networks. Neuron. 1992;8:429-440
[84] Holzwarth JA, Gibbons SJ, Brorson JR, Philipson LH, Miller RJ. Glutamate receptor ago-
nists stimulate diverse calcium responses in different types of cultured rat cortical glial 
cells. The Journal of Neuroscience 1994;14:1879-1891
[85] Seifert G, Steinhäuser C. Glial cells in the mouse hippocampus express AMPA recep-
tors with an intermediate Ca2+ permeability. The European Journal of Neuroscience. 
1995;7:1872-1881. DOI: 10.1111/j.1460-9568.1995.tb00708.x
[86] Steinhauser C, Jabs R, Ket H. Properties of GABA and glutamate responses in identified 
glial cells of the mouse hippocampal slice. Hippocampus. 1994;4:19-36
[87] Porter JT, McCarthy KD. GFAP-positive hippocampal astrocytes in situ respond to glu-
tamatergic neuroligands with increases in [Ca2+]i. Glia. 1995;13:101-112. DOI: 10.1002/
glia.440130204
[88] Conti F, Minelli A, Molnar M, Brecha NC. Cellular localization and laminar distribution 
of NMDAR1 mRNA in the rat cerebral cortex. The Journal of Comparative Neurology. 
1994;343:554-565
[89] Gracy KN, Pickel VM. Comparative ultrastructural localization of the NMDAR1 gluta-
mate receptor in the rat basolateral amygdala and bed nucleus of the stria terminalis. 
Journal of Comparative Neurology. 1995;362:71-85
[90] Conti F, DeBiasi S, Minelli A, Melone M. Expression of NR1 and NR2A/B subunits of the 
NMDA receptor in cortical astrocytes. Glia. 1996;17:254-258
[91] Petralia RS, Wang YX, Zhao HM, Wenthold, R.J.Wenthold RJ. Ionotropic and metabo-
tropic glutamate receptors show unique postsynaptic, presynaptic, and glial localizations 
in the dorsal cochlear nucleus. The Journal of Comparative Neurology 1996;372:356-383. 
DOI: 10.1016/0306-4522(95)00533-1
Astrocyte - Physiology and Pathology84
[92] Van Bockstaele EJ, Colago EEO. Selective distribution of the NMDA-R1 glutamate recep-
tor in astrocytes and presynaptic axon terminals in the nucleus locus coeruleus of the rat 
brain: An immunoelectron microscopic study. The Journal of Comparative Neurology. 
1996;369:483-496. DOI: 10.1002/(SICI)1096-9861(19960610)369:4<483::AID-CNE1>3.0.CO;2-0
[93] Farb CR, Aoki C, Ledoux JE. Differential localization of NMDA and AMPA receptor 
subunits in the lateral and basal nuclei of the amygdala: A light and electron micro-
scopic study. The Journal of Comparative Neurology. 1995;362:86-108. DOI: 10.1002/cne. 
903620106
[94] Pasti L, Volterra A, Pozzan T, Carmignoto G. Intracellular calcium oscillations in astro-
cytes: A highly plastic, bidirectional form of communication between neurons and 
astrocytes in situ. The Journal of Neuroscience. 1997;17:7817-7830. DOI: 10.1038/nrn1722
[95] Cai Z, Kimelberg HK. Glutamate receptor-mediated calcium responses in acutely iso-
lated hippocampal astrocytes. Glia. 1997;21:380-389
[96] Gottlieb M, Matute C. Expression of ionotropic glutamate receptor subunits in glial 
cells of the hippocampal CA1 area following transient forebrain ischemia. Journal of 
Cerebral Blood Flow and Metabolism. 1997;17:290-300
[97] Nishizaki T, Matsuoka T, Nomura T, Kondoh T, Tamaki N, Okada Y. Store Ca2+ deple-
tion enhances NMDA responses in cultured human astrocytes. Biochemical and 
Biophysical Research Communications. 1999;259:661-664
[98] Shelton MK, Mccarthy KEND. Mature hippocampal astrocytes exhibit functional metabo-
tropic and ionotropic glutamate receptors in situ. Glia. 1999;26:1-11
[99] Conti F, Barbaresi P, Melone M, Ducati A. Neuronal and glial localization of NR1 and 
NR2A/B subunits of the NMDA receptor in the human cerebral cortex. Cerebral Cortex. 
1999;9:110-120. DOI: 10.1093/cercor/9.2.110
[100] Schipke CG, Ohlemeyer C, Matyash M, Nolte C, Kettenmann H, Kirchhoff F. Astrocytes 
of the mouse neocortex express functional N-methyl-D-aspartate receptors. The FASEB 
Journal. 2001;15:1270-1272
[101] Kondoh T, Nishizaki T, Aihara H, Tamaki N. NMDA-responsible, APV-insensitive 
receptor in cultured human astrocytes. Life Sciences. 2001;68:1761-1767
[102] Krebs C, Fernandes HB, Sheldon C, Raymond LA, Baimbridge KG. Functional NMDA 
receptor subtype 2B is expressed in astrocytes after ischemia in vivo and anoxia in vitro. 
The Journal of Neuroscience. 2003;23:3364-3372
[103] Zhang Q, Hu B, Sun S, Tong E. Induction of increased intracellular calcium in astrocytes 
by glutamate through activating NMDA and AMPA receptors. Journal of Huazhong 
University of Science and Technology. Medical Sciences. 2003;23:254-257. DOI: 10.1007/
BF02829506
[104] Hu B, Sun S-G, Tong E-T. NMDA and AMPA receptors mediate intracellular calcium 
increase in rat cortical astrocytes 1. Acta Pharmacologica Sinica. 2004;25:714-720
NMDA Receptors in Astroglia: Chronology, Controversies, and Contradictions from a Complex Molecule
http://dx.doi.org/10.5772/intechopen.72975
85
[105] Lalo U, Pankratov Y, Kirchhoff F, North RA, Verkhratsky A. NMDA receptors medi-
ate neuron-to-glia signaling in mouse cortical astrocytes. The Journal of Neuroscience. 
2006;26:2673-2683
[106] Wang X, Lou N, Xu Q, Tian G-F, Peng WG, Han X, et al. Astrocytic Ca2+ signaling evoked 
by sensory stimulation in vivo. Nature Neuroscience. 2006;9:816-823. DOI: 10.1038/nn1703
[107] Serrano A. GABAergic network activation of glial cells underlies hippocampal hetero-
synaptic depression. The Journal of Neuroscience. 2006;26:5370-5382. DOI: 10.1523/
JNEUROSCI.5255-05.2006
[108] Kato H, Narita M, Miyatake M, Yajima Y, Suzuki T. Role of neuronal NR2B subunit-
containing NMDA receptor-mediated Ca2+ influx and astrocytic activation in cultured 
mouse cortical neurons and astrocytes. Synapse. 2006;59:10-17
[109] Edling Y, Ingelman-Sundberg M, Simi A. Glutamate activated c-fos in glial cells via a 
novel mechanism involving the glutamate receptor subtype mGlu5 and the transcrip-
tional repressor DREAM. Glia. 2007;55:328-340. DOI: 10.1002/glia
[110] Cahoy JD, Emery B, Kaushal A, Foo LC, Zamanian JL, Christopherson KS, et al. A 
transcriptome database for astrocytes, neurons, and oligodendrocytes: A new resource 
for understanding brain development and function. The Journal of Neuroscience. 
2008;28:264-278. DOI: 10.1523/JNEUROSCI.4178-07.2008
[111] Serrano A, Robitaille R, Lacaille JC. Differential NMDA-dependent activation of glial 
cells in mouse hippocampus. Glia. 2008;56:1648-1663. DOI: 10.1002/glia.20717
[112] Palygin O, Lalo U, Verkhratsky A, Pankratov Y. Ionotropic NMDA and P2X1/5 recep-
tors mediate synaptically induced Ca2+ signalling in cortical astrocytes. Cell Calcium. 
2010;48:225-231
[113] Lee MC, Ting KK, Adams S, Brew BJ, Chung R, Guillemin GJ. Characterisation of the 
expression of NMDA receptors in human astrocytes. PLoS One. 2010;5:e14123
[114] Jiang J, Yan M, Lv Q, Cheng C, Li X, Guo Z, et al. Inhibition of nitric oxide-induced 
nuclear localization of CAPON by NMDA receptor antagonist in cultured rat primary 
astrocytes. Neurochemistry International. 2010;56:561-568
[115] Holmes KD, Mattar P, Marsh DR, Jordan V, Weaver LC, Dekaban GA. The C-terminal 
C1 cassette of the N-methyl-D-aspartate receptor 1 subunit contains a bi-partite 
nuclear localization sequence. Journal of Neurochemistry. 2002;81:1152-1165. DOI: 
10.1046/j.1471-4159.2002.00865.x
[116] Jeffrey RA, Ch’ng TH, O’Dell TJ, Martin KC. Activity-dependent anchoring of Importin 
at the synapse involves regulated binding to the cytoplasmic tail of the NR1-1a sub-
unit of the NMDA receptor. The Journal of Neuroscience. 2009;29:15613-15620. DOI: 
10.1523/JNEUROSCI.3314-09.2009
[117] Zhou Y, Li HL, Zhao R, Yang LT, Dong Y, Yue X, et al. Astrocytes express N-methyl-
D-aspartate receptor subunits in development, ischemia and post-ischemia. Neuro-
chemical Research. 2010;35:2124-2134. DOI: 10.1007/s11064-010-0325-x
Astrocyte - Physiology and Pathology86
[118] Palygin O, Lalo U, Pankratov Y. Distinct pharmacological and functional properties 
of NMDA receptors in mouse cortical astrocytes. British Journal of Pharmacology. 
2011;163:1755-1766. DOI: 10.1111/j.1476-5381.2011.01374.x
[119] Lalo U, Palygin O, North RA, Verkhratsky A, Pankratov Y. Age-dependent remodel-
ling of ionotropic signalling in cortical astroglia. Aging Cell. 2011;10:392-402. DOI: 
10.1111/j.1474-9726.2011.00682.x
[120] Martins-De-Souza D, Lebar M, Turck CW. Proteome analyses of cultured astro-
cytes treated with MK-801 and clozapine: Similarities with schizophrenia. European 
Archives of Psychiatry and Clinical Neuroscience. 2011;261:217-228. DOI: 10.1007/
s00406-010-0166-2
[121] Gerard F, Hansson E. Inflammatory activation enhances NMDA-triggered Ca2+ sig-
nalling and IL-1beta secretion in primary cultures of rat astrocytes. Brain Research. 
2012;1473:1-8
[122] Orre M, Kamphuis W, Osborn LM, Melief J, Kooijman L, Huitinga I, et al. Acute isolation 
and transcriptome characterization of cortical astrocytes and microglia from young and 
aged mice. Neurobiology of Aging. 2014;35:1-14. DOI: 10.1016/j.neurobiolaging.2013.07.008
[123] Rusnakova V, Honsa P, Dzamba D, Ståhlberg A, Kubista M, Anderova M. Heterogeneity 
of astrocytes: From development to injury - single cell gene expression. PLoS One. 
2013;8. DOI: 10.1371/journal.pone.0069734
[124] Zhang Y, Chen K, Sloan SA, Bennett ML, Scholze AR, O’Keeffe S, et al. An RNA-
sequencing transcriptome and splicing database of glia, neurons, and vascular cells of 
the cerebral cortex. The Journal of Neuroscience. 2014;34:11929-11947. DOI: 10.1523/
JNEUROSCI.1860-14.2014
[125] Haustein MD, Kracun S, XH L, Shih T, Jackson-Weaver O, Tong X, et al. Conditions and 
constraints for astrocyte calcium signaling in the hippocampal mossy fiber pathway. 
Neuron. 2014;82:413-429. DOI: 10.1016/j.neuron.2014.02.041
[126] Jimenez-Blasco D, Santofimia-Castaño P, Gonzalez A, Almeida A, Bolaños JP. Astrocyte 
NMDA receptors’ activity sustains neuronal survival through a Cdk5-Nrf2 pathway. 
Cell Death and Differentiation. 2015;22:1877-1889. DOI: 10.1038/cdd.2015.49
[127] Obara-Michlewska M, Ruszkiewicz J, Zielińska M, Verkhratsky A, Albrecht J. Astroglial 
NMDA receptors inhibit expression of K
ir
 4.1 channels in glutamate-overexposed 
astrocytes in vitro and in the brain of rats with acute liver failure. Neurochemistry 
International. 2015;88:20-25. DOI: 10.1016/j.neuint.2014.10.006
[128] Morquette P, Verdier D, Kadala A, Féthière J, Philippe AG, Robitaille R, et al. An 
astrocyte-dependent mechanism for neuronal rhythmogenesis. Nature Neuroscience. 
2015;18:844-854. DOI: 10.1038/nn.4013
[129] Otsu Y, Couchman K, Lyons DG, Collot M, Agarwal A, Mallet J, et al. Calcium dynam-
ics in astrocyte processes during neurovascular coupling. Nature Neuroscience. 2015; 
18:210-218. DOI: 10.1038/nn.3906
NMDA Receptors in Astroglia: Chronology, Controversies, and Contradictions from a Complex Molecule
http://dx.doi.org/10.5772/intechopen.72975
87
[130] Srinivasan R, Huang BS, Venugopal S, Johnston AD, Chai H, Zeng H, et al. Ca2+ signal-
ing in astrocytes from Ip3r2−/− mice in brain slices and during startle responses in vivo. 
Nature Neuroscience. 2015;18:708-717. DOI: 10.1038/nn.4001
[131] Shigetomi E, Tong X, Kwan KY, Corey DP, Khakh BS. TRPA1 channels regulate astrocyte 
resting calcium and inhibitory synapse efficacy through GAT-3. Nature Neuroscience. 
2011;15:70-80. DOI: 10.1038/nn.3000
[132] Dzamba D, Honsa P, Valny M, Kriska J, Valihrach L, Novosadova V, et al. Quantitative 
analysis of glutamate receptors in glial cells from the cortex of GFAP/EGFP mice follow-
ing ischemic injury: Focus on NMDA receptors. Cellular and Molecular Neurobiology. 
2015;35:1187-1202. DOI: 10.1007/s10571-015-0212-8
[133] Yu W, Zhu H, Wang Y, Li G, Wang L, Li H. Reactive transformation and increased bdnf 
signaling by hippocampal astrocytes in response to mk-801. PLoS One. 2015;10:1-13. 
DOI: 10.1371/journal.pone.0145651
[134] Pinacho R, Vila E, Prades R, Tarragó T, Castro E, Ferrer I, et al. The glial phosphorylase 
of glycogen isoform is reduced in the dorsolateral prefrontal cortex in chronic schizo-
phrenia. Schizophrenia Research. 2016;177:37-43. DOI: 10.1016/j.schres.2016.04.024
[135] Mehina EMF, Murphy-Royal C, Gordon GR. Steady-state free Ca2+ in astrocytes is 
decreased by experience and impacts arteriole tone. The Journal of Neuroscience. 
2017;37:8150-8165. DOI: 0.1523/JNEUROSCI.0239-17.2017
[136] Lopez-Colome AM, Ortega A, Romo-de-Vivar M. Excitatory amino acid-induced phos-
phoinositide hydrolysis in Muller glia. Glia. 1993;9:127-135
[137] López-Colomé AM, Ortega A, Fragoso G, Trueba E. Excitatory amino acid receptors 
coupled to the phosphoinositide pathway in Bergmann glia. Neurochemical Research. 
1997;22:305-312. DOI: 10.1023/A:1022494923084
[138] Rodríguez-Moreno A, Sihra TS. Kainate receptors with a metabotropic modus ope-
randi. Trends in Neurosciences. 2007;30:630-637. DOI: 10.1016/j.tins.2007.10.001
[139] Khakh BS, McCarthy KD. Astrocyte calcium signaling: From observations to functions 
and the challenges therein. Cold Spring Harbor Perspectives in Biology. 2015;7:a020404. 
DOI: 10.1101/cshperspect.a020404
[140] Kettenmann H, Ransom B, editors. Neuroglia. 3rd ed. New York: Oxford; 2013
[141] Nedergaard M, Rodr??guez JJ, Verkhratsky A. Glial calcium and diseases of the ner-
vous system. Cell Calcium. 2010;47:140-149. DOI: 10.1016/j.ceca.2009.11.010
[142] Chung CNMDA. Receptor as a newly identified member of the metabotropic gluta-
mate receptor family: Clinical implications for neurodegenerative diseases. Molecules 
and Cells. 2013;36:99-104. DOI: 10.1007/s10059-013-0113-y
[143] Gonzalez-Hernandez JR, Montes de Oca Balderas P. Mitochondrial Membrane Potential 
Response to NMDA and MK-801 in rat cultured cortical astrocytes. In: 2nd Congress 
of the Neurobiology Branch de la Sociedad Mexicana de Bioquímica. October 15-18, 
Querétaro, México. 2017
Astrocyte - Physiology and Pathology88
[144] Montes de Oca Balderas P, Aguilera P, Santamaria A. N-Methyl D-Aspartate Receptor 
is expressed by Rat Cultured Cortical Astrocytes and Regulates their Mitochondrial 
Membrane Potential. Congress of the Society of Neuroscience. November 9-13 San 
Diego, CA. USA. 2013
[145] Khakh BS, Sofroniew MV. Diversity of astrocyte functions and phenotypes in neural 
circuits. Nature Neuroscience. 2015;18:942-952. DOI: 10.1038/nn.4043
[146] Matyash V, Kettenmann H. Heterogeneity in astrocyte morphology and physiology. 
Brain Research Reviews. 2010;63:2-10
[147] Clements JD, Lester RA, Tong G, Jahr CE, Westbrook GL. The time course of glutamate 
in the synaptic cleft. Science (80-). 1992;258:1498-1501
[148] Leibowitz A, Boyko M, Shapira Y, Zlotnik A. Blood glutamate scavenging: Insight into 
neuro protection. International Journal of Molecular Sciences. 2012;13:10041-10066. 
DOI: 10.3390/ijms130810041
[149] Lee FJS, Liu F. Direct interactions between NMDA and D1 receptors: A tale of tails. 
Biochemical Society Transactions. 2004;32:1032-1036. DOI: 10.1042/BST0321032
[150] Pauly T, Ratliff M, Pietrowski E, Neugebauer R, Schlicksupp A, Kirsch J, et al. Activity-
dependent shedding of the NMDA receptor glycine binding site by matrix metallopro-
teinase 3: A PUTATIVE mechanism of postsynaptic plasticity. PLoS One. 2008;3:e2681
[151] Montes de Oca BP. Ectdomain shedding and regulated intracellular proteolysis in 
the central nervous system. Central Nervous System Agents in Medicinal Chemistry. 
2010;10:337-359
[152] Meisenbock G, De Angelis DA, Rothman JE. Visualizing sectretion and synaptic trans-
mission with pH-sensitive green fluorescent proteins. Nature. 1998;394:192-195. DOI: 
10.1038/nature00909.1
[153] Chesler M. Regulation and modulation of pH in the brain. Physiological Reviews. 
2003;83:1183-1221. DOI: 10.1152/physrev.00010.2003
[154] Bernardinelli Y, Randall J, Janett E, Nikonenko I, König S, Jones EV, et al. Activity-
dependent structural plasticity of perisynaptic astrocytic domains promotes excitatory 
synapse stability. Current Biology. 2014;24:1679-1688. DOI: 10.1016/j.cub.2014.06.025
[155] Heller JP, Rusakov DA. Morphological plasticity of astroglia: Understanding synaptic 
microenvironment. Glia. 2015;63:2133-2151. DOI: 10.1002/glia.22821
[156] Patrushev I, Gavrilov N, Turlapov V, Semyanov A. Subcellular location of astrocytic 
calcium stores favors extrasynaptic neuron-astrocyte communication. Cell Calcium. 
2013;54:343-349. DOI: 10.1016/j.ceca.2013.08.003
[157] Montes de Oca Balderas P, Montes de Oca Balderas H. Synaptic neuron-astrocyte com-
munication is supported by an order of magnitude analysis of inositol tris-phosphate dif-
fusion at the nanoscale in a model of peri-synaptic astrocyte projection. BMC Biophysics. 
2018. Accepted with minor reviews
NMDA Receptors in Astroglia: Chronology, Controversies, and Contradictions from a Complex Molecule
http://dx.doi.org/10.5772/intechopen.72975
89

